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Abstract 
Proteases are industrially important enzymes and have niche applications in 
diagnostic kits that use cell lysis and thereby require high resistance towards 
chaotropic salts and detergents, such as guanidinium chloride (GdmCl) and 
sodium dodecylsulfate (SDS). Subtilisin E, a well-studied serine protease, was 
selected to be re-engineered by directed evolution into a “chaotolerant” 
protease that would be resistant towards GdmCl and SDS, for application in 
diagnostic kits. In three iterative rounds of directed evolution, the variant 
SeSaM1-5 (S62I/A153V/G166S/I205V), designated as M4, was generated, 
with improved activity (330 % on Suc-AAPF-AMC) and increased half life in 1 
M GdmCl (<2 min to 4.7 h) or in 0.5 % SDS (<2 min to 2.7 h). 
    Saturation mutagenesis in the subtilisin E wild type gene of each site 
identified in directed subtilisin E evolution revealed that positions 62, 166, 218 
and 224 were mainly responsible for increased activity and for GdmCl or SDS 
resistance. A double mutant, M2 (S62I/G166M), generated by combination of 
the best two single substitutions showed significantly improved kinetic 
constants; in 2 M GdmCl the Km value decreased (29 fold) from 7.31 to 0.25 
mM, and the kcat values increased (4 fold) from 15 to 61 s
-1. The catalytic 
efficiency, kcat/Km, improved dramatically (GdmCl: 247 mM
-1 · s-1 (118-fold); 
SDS, 179 mM-1∙ s-1 (13-fold)). In addition, M4 showed longer half life in 2.0 % 
SDS when compared to the wild-type (t1/2 54.8 min (>27 fold)).  
    Two other variants, M5 (S62I/A153V/G166S/T224A/T240S) and M6 (S62I/ 
A153V/G166S/I205V/N218S/T224A) were constructed by combination of 
additional beneficial substitutions for further improvement of activity and 
resistance towards GdmCl and SDS. Inactivation curves showed that the 
activity of M6 towards Suc-AAPF-pNA as substrate was much improved 
compared to M4 in the presence of up to 5 M GdmCl (IC50 (M4): 2.7 M; IC50 
(M6): 4.6 M) and up to 4 % SDS (IC50 (M4): 1.5 % ; IC50 (M6): 4.0 %). Half life 
iv 
 
value of M6 in the presence of GdmCl was also increased (3 M GdmCl: t1/2 68 
min; 2 % SDS: t1/2 66 min). M5 was slightly more active in GdmCl but less 
active in SDS compared to M4. Additionally M5 was more active towards 
complex protein substrate (Azocasein) when compared to both M4 and M6.  
However, M5 was not stable in GdmCl or SDS in terms of its half life. Circular 
dichroism (CD) spectra analysis showed that secondary structures of subtilisin 
E wild type and three mutants (M4, M5 and M6) were almost intact at lower 
concentrations of GdmCl (1-2 M) and SDS (0.5-2.0 %), indicating inactivation 
precedes conformation changes in subtilisin E in the presence of chaotropic 
agents. 
    Finally, model building, molecular docking and molecular dynamics (MD) 
simulations of subtilisin E wild type showed that the guanidinium cation (Gdm+) 
or the monomeric dodecylsulfate anion (DS-) are likely to directly interact with 
the active site or substrate binding pocket residues, probably limiting the 
access of the substrate to the catalytic centre. Simulations of M4 indicated that 
the residues forming part of the active site or substrate binding pocket of the 
mutant are less affected or accessible by Gdm+ or DS-.  
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Abbreviation 
Amp Ampicillin  
BSA Bovine serum albumin 
B. subtilis Bacillus subtilis 
CD Circular dichroism 
CV Coefficient of variations  
DMF Dimethylformamide 
DS- Dodecylsulfate anion 
E. coli Escherichia coli  
epPCR Error-prone PCR 
GdmCl Guanidinium chloride 
Gdm+ Guanidinium cation 
MAP Mutagenesis assistant program 
MD Molecular Dynamics 
MTP Microtiter plate 
PLICing Phosphorothioate-based ligase-independent gene cloning 
RMSD Root mean square deviations 
RMSF Root mean square fluctuations 
SASA Solvent accessible surface area 
SDF Spatial distribution functions 
SDM Site directed mutagenesis 
SDS Sodium dodecylsulfate 
SeSaM Sequence saturation mutagenesis 
SSM Site saturation mutagenesis 
StEP Staggered extension process 
Suc-AAPF-AMC Succinyl-Ala-Ala-Pro-Phe-7-amino-4-methylcoumarin 
Suc-AAPF-pNA Succinyl- Ala-Ala-Pro-Phe-p-nitroanilide 
Tet Tetracycline 
WT Wild type 
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1. Introduction 
1.1 Proteases 
1.1.1 Brief introduction 
1.1.1.1 Protease 
Proteases are an important family of hydrolases, which includes proteinases and 
peptidases, and defined as a class of enzymes which catalyzes the hydrolytic 
breakdown of proteins through the peptide bond. Proteases can be found in all forms 
of life on the earth, including prokaryotes, fungi, plants and animals [1]. Proteases can 
be divided into four subgroups: 1) serine proteases, 2) aspartic proteases, 3) cysteine 
proteases, and 4) metalloproteases based on their catalytic site and mechanism [2]. 
Almost one-third of all proteases can be classified as serine proteases (named from 
serine residue at the active site for nucleophilic attack of peptide bond). Mechanism of 
serine proteases normally consists of an Asp-His-Ser catalytic triad system. By the 
differences of structural contexts serine proteases can be further divided into six clans. 
The Asp-His-Ser catalytic triad can be found in four clans: chymotrypsin (SA), 
subtilisin (SB), carboxypeptidase Y (SC) and Clp protease (SK) [3]. Figure 1.1 shows 
the catalytic triad in a typical serine protease subtilisin [4].  
1.1.1.2 Subtilisin E 
Subtilisin is an important group within the serine protease family and a very important 
industrial enzyme. It has served as a model enzyme for protein engineering 
investigation. It has many advantages, such as enormous rate of enhancements, 
timely cloning of the gene, ease of expression, purification and availability of atomic 
resolution structures. This has be proven by the fact that over 50 % of the 275 amino 
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Figure 1.1 Schematic diagram of the active site of subtilisin. A) Active regions. A region of a 
bound polypeptide inhibitor is shown in red. The four essential features of the active site are 
highlighted in yellow 
[4]
. B) The catalytic group interacting with polypeptide substrate binding to 
P1-P4 sites (Nomenclature for substrate amino acid residues is Pn) 
[5]
.  
 
acids have been already mutated [6]. Though there are many types of subtilisins 
available, the most mutagenized are those secreted by Bacillus amyloliquefaciens 
(subtilisin BPN’), subtilis (subtilisin E) and lentus (savinase). 
    Subtilisin E is an alkaline serine protease that is produced by Bacillus subtilis 168 
[7]. Like other subtilisin counterparts, it is encoded as a pre-pro-peptide. The 
N-terminal pre-sequence is a signal peptide responsible for secretion, while the 
pro-sequence is considered as a chaperone, allowing the correct folding of the 
protease, and then being cleaved by the mature protease itself [8]. Thus, unfolding of 
the mature protease is irreversible. As in most subtilisins, its catalytic triad consists of 
aspartic acid, histidine and serine (see Figure 1.2).  
    Up to now, site-directed mutagenesis (SDM) and directed evolution have been 
used in the study of subtilisin E. For instance, the introduction of an additional 
disulfide bond linkage between residues Cys 61 and Cys 98 using SDM method 
resulted in the increased thermostability [9]. SDM has also been employed in the 
construction of subtilisin variants showing improved storage and oxidation stabilities 
[10]. A mutant subtilisin E with enhanced thermostability at 60°C was generated using 
SDM, by forming a disulfide bridge between two subtilisin E molecules having the 
Ser236Cys substitution [11].  
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Figure 1.2 Structure of the subtilisin-propeptide complex. The subtilisin domain is shown in 
amber and the propeptide domain in magenta. Subtilisin’s three catalytic residues of the active 
site are Asp32, His64 and Ser221 
[12]
. 
1.1.2 Application of protease in industry 
The use of proteases has been widely applied to degradation of proteins in industrial 
process. Proteases account for approximately 40 % of the total enzyme sales in 
various industrial market sectors, such as detergent, food, pharmaceutical, leather, 
diagnostics, waste management and silver recovery [1]. Proteases for detergent 
occupy great section in the application of proteases in industry, so that great efforts 
are being made for novel proteases in this field [13]. In addition, proteases can be used 
in the removal of protein pollution as an additive in various cleaning and washing 
process related to environmental issues. In these decades, the stability of proteases 
under unfavorable industrial conditions is of great interest.  
    The term “stability” refers to a protein's resistance to adverse influences such as 
heat or denaturants, that is, to the persistence of its molecular integrity or biological 
function in the face of high temperatures or other deleterious influences [14]. 
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    Naturally available enzymes are usually not optimally suited for industrial 
applications due to their poor performance under industrial process conditions, such 
as high temperature, extreme pH and organic cosolvent. This can often be related to a 
stability of enzymes under those conditions. Thus, the use of stable enzymes under 
such conditions is often desirable in industry.  
    The stability of an enzyme is affected by many factors, such as temperature, pH, 
oxidative stress, solvent properties, the binding of metal ions or co-factors, and the 
presence of surfactants. Among these variables, the effect of temperature is the best 
studied. 
    Up until now, there are three biotechnological approaches to generate stable 
variants of a given protein: 1) isolating enzyme variants from organisms living in 
appropriate extreme environments [15]; 2) rationale-based mutagenesis [16] and 3) 
directed evolution [17]. Combinations of strategies (e.g. rational and evolutionary 
design) can reduce development times significantly and broaden our understanding of 
structure-function relationships. 
    Very interestingly, proteases were among the first enzymes to be targeted for 
directed evolution approach, mainly because of the need for stable and functional 
variants in detergent applications. One of the early studies on family shuffling of 26 
subtilisins from Bacillus species for multiple properties: activity at 23°C and at three 
different pH values, thermostability and solvent stability (35 % DMF) [18]. It was 
reported that the best variants had up to three times more residual activity after heat 
treatment or up to 50 % greater residual activity in DMF. This revealed that new, 
valuable combinations of properties had been achieved, including considerable 
increases in stability. 
    The directed evolution application in protease stability is mainly on subtilisins, 
such as subtilisin E (see section 1.2) and its homologs. For instance, subtilisin S41 
variant was 100-fold more thermostable than its wide type by using epPCR method 
[19].   
    Except the thermostability or stability in organic solvent, to our knowledge there 
are no studies in directed evolution applied to high resistance or stability of protease 
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in chaotropes (except some organic solvents) so far. Therefore, this project will make 
great contributions to broaden the research boundary concerning protease stability 
and deepen our understanding of structure-function relationship which governs 
chaotrope resistance of proteases. 
1.2 Protease engineering by directed evolution 
Directed evolution has been, during the past decades, a successful and promising 
approach for tailoring protein properties to industrial demands and advancing our 
understanding of structure-function relationships of biocatalysts.  
    The origin of directed evolution was derived from Spiegelman’s concept 
“evolution in a test tube” [20]. Since then, the concept developed into a powerful 
algorithm as an increasing number of successful stories proved. Up to now, this 
method has been used in a wide range of applications, such as improving 
enantioselectivity [21], enzymes for bioremediation [22], and vaccines [23]. 
    Though directed evolution comes from the idea of imitating Darwin’s evolution 
process in laboratory rather than under natural evolutionary pressure, the former 
usually takes only few weeks or months whereas the later might takes thousands of 
years.  
    The directed evolution usually consists of three steps as illustrated in Figure 1.3. 
1) Diversity generation; 2) Screening for improved variants; 3) Isolating the gene 
encoding for the improved protein variant. Iterative cycles are normally required until 
the desired property has been changed or improved significantly. 
    During the whole process, the first two steps are essential for a successful 
directed evolution experiments. However, it is still a challenge to generate an 
unbiased mutant library [24], and a challenge in setting up the screening systems. For 
instance, some high throughput screening techniques require further development to 
improve their accessibility. 
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Figure 1.3 Overview of a typical directed evolution procedure. A gene library with diversity is 
generated firstly based on the wild type as template. An effective screening system is then 
applied to screen for the variants with improved properties as expected. The improved variant 
selected is considered as a new template for the next round of library generation. Iterative 
rounds of such process are usually performed until the desired variant is selected. 
1.2.1 Diversity generation 
During the past decades, more and more novel methods, besides DNA and genome 
shuffling for diversity generation have emerged. It is notable that a research begins 
focusing on the quality and comprehensiveness of library construction and analysis [25]. 
An increasing number of powerful new combinatorial techniques have joined rational 
design methods as effective tools for the manipulation and tailoring of biocatalysts, 
such as staggered extension process (StEP) [26], random chimeragenesis on transient 
templates (RACHITT) [27] and iterative truncation for the creation of hybrid enzymes 
(ITCHY) [28]. These advances are summarized in some recent literature [29]. Despite of 
this, some conventional methods, like error-prone PCR, due to its simplicity, are still 
widely used. 
Error-prone PCR (epPCR) 
The most commonly used random mutagenesis techniques are the PCR methods 
under low fidelity conditions. Taq DNA polymerase from Thermus aquaticus that lacks 
a 3’-5’ proofreading exonuclease activity, is usually used [30]. According to its 
error-prone percentage, it gives around one mutation per 125,000 bp per PCR cycle 
which is insufficient for randomizing genes that seldom exceed 5,000 bp in length. 
There are many different ways of increasing the error rates of the polymerase, such 
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as by adding unbalancing nucleotide concentrations and/or chemical compounds 
such as manganese chloride, employing nucleotide analogs, increased extension 
times, etc [31]. 
    Though epPCR based methods are quite simple, its disadvantages are obvious, 
like high number of transitions, lack of consecutive nucleotide exchange which makes 
it impossible to obtain some amino acid substitutions. There are also a high probability 
of stop codons and disruptive amino acids like Gly and Pro [32]. 
Sequence Saturation Mutagenesis (SeSaM) 
In our group, a novel diversity generation method was developed and termed as 
Sequence Saturation Mutagenesis (SeSaM). SeSaM overcomes the current 
limitations caused by biased polymerases. Moreover, SeSaM can target a nucleotide 
species of the selected sequence and each nucleotide species can be exchanged in a 
controlled manner since SeSaM regulates the mutational spectra through a universal 
base [33]. 
 Figure 1.4 Overview of SeSaM method (http://www.sesam-biotech.com/sesamtech.html). 
    The SeSaM method comprises four steps (see Figure 1.4): Step 1, A PCR to 
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incorporate phosphorothioate nucleotides into the gene of interest followed by 
cleavage of the phosphorothioate bonds to create evenly distributed fragments of the 
gene; Step 2, Elongation of fragments in Step 1 with universal bases at 3’-OH terminal; 
Step 3, Fragments with the universal bases are elongated to their full length using the 
full length gene template; Step 4, Mutations are generated opposite to universal 
bases in a final amplification PCR. 
SeSaM-based shuffling 
A novel combinatorial mutagenesis method is designed based on SeSaM method and 
termed as “SeSaM-based shuffling”. This is an alternative method for other widely 
used combinational methods such as gene shuffling or StEP [26]. The concept is gene 
fragmentation and recombination on SeSaM platform by using one wild type gene 
(WT) and one synthetic gene (MX) which includes all substitutions of interest. The 
procedure comprising four steps are shown in Figure 1.5: Step 1, gene template 
generation derived from SeSaM preparation step; Step 2, SeSaM PCRs (SeSaM 
biotin primers) and cleavage (iodine under alkaline conditions) derived from SeSaM 
step 1; Step 3, SeSaM full length synthesis derived from SeSaM step3; Step 4, 
Standard PCR amplification. Original SeSaM step 2 is not included since the addition 
of universal base is not required.  
    The key step is step 3 (see Figure 1.5), in which extension of PCR cycles can 
generate different recombination patterns. Besides, the ratio of amount of wild type 
and synthetic gene can also affect the recombination results. Thus these conditions 
should be optimized in order to obtain a combinatorial mutagenesis library with 
randomly distributed and combined mutations. 
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Figure 1.5 Overview of SeSaM-based shuffling procedure. The complete procedure includes 
four steps: Step 1, Template generation; Step 2, SeSaM PCRs (SeSaM biotin primers) and 
Cleavage (iodine); Step 3, SeSaM full length synthesis; Step 4, Standard PCR amplification. 
WT, wild type; MX, synthetic gene mutant (mutations highlighted in yellow). 
1.2.2 Screening systems 
Solid phase and microtiter plate based screening are still routinely and widely used in 
directed evolution, despite of the increasing number of novel screening methods 
available, such as in vitro compartmentalization [34] and cell surface display [35].  
    Solid phase, mainly agar plate screening, is usually based on color change, so 
that the activity difference could be simply distinguishable by observation. However, it 
lacks accuracy and therefore not suitable for quantitative activity measurements. In 
contrast, microtiter plate assays can be used to screen for up to 105 clones and are 
suitable for quantitative measurement, although practically this number of clones is 
seldom reached (see Figure 1.6).  
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Figure 1.6 Comparison of commonly used screening systems for directed evolution. Solid 
phase screening and microtiter plate screening are based on color change or fluorescent 
change which follows enzymatic reaction, using either chromogenic substrate or coupled 
reaction of substrate. 
1.2.3 Directed evolution of subtilisin E 
Directed evolution can effectively alter protein properties despite any understanding of 
the targeted characteristic (random mutant libraries) in contrast to SDM (focused 
mutant libraries) which requires the identification of specific targets in a protein 
structure. Table 1.7 lists the representative successful directed evolution examples 
employing subtilisin E. The total activity and organic solvent stability of subtilisin E has 
been enhanced in aqueous dimethyl formamide (DMF) using a directed evolution 
approach [36]. To demonstrate the utility of this method, Staggered Extension Process 
(StEP) PCR was used to recombine a set of five thermostabilized subtilisin E variants 
identified during a single round of error-prone PCR mutagenesis and screening. 
Screening the StEP-recombined library yielded a subtilisin variant whose half-life was 
increased 50-fold at 65 °C, compared with wild type [37]. Shao used random-priming 
for generation of the mutant library, which could be also effective to elongate the half 
life [38]. In another report, the thermal stability of subtilisin E was increased by 
converting it into a thermitase using directed evolution [39]. 
    To date, there are no reports available of subtilisin E regarding its resistance 
towards chaotropic agents, especially chaotropic salts or detergents. However, some 
 
Chapter 1 - Introduction 
11 
 
early references stated that subtilisins had modest tolerance towards chaotropic 
agents, like guanidinium chloride (GdmCl), as well as some detergents [40]. Thus, 
subtilisin E, though it is a mesophilic protease, is still regarded as a suitable protease 
candidate for evolution into a better chaotolerant protease for further applications. 
1.3 Stability of enzymes in chaotropes 
1.3.1 Chaotropes 
A chaotrope (chaotropic agent) is a substance which disrupts and denatures the 
structure of macromolecules such as proteins and nucleic acids (e.g. DNA and RNA, 
not discussed in this dissertation). 
    Chaotropic solutes can interfere with intramolecular interactions within proteins 
mediated by non-covalent forces, like van der Waals forces, hydrogen bonding and 
hydrophobic forces, and thus increase the entropy of the system. The structure and 
function of proteins mostly depend on the net effect of these forces, therefore an 
increase of the entropy in chaotropic solutes in a biological system will denature 
proteins or reduce enzymatic activity. Tertiary protein folding mostly relies on 
hydrophobic forces from amino acids determined by the sequence of the protein. 
Conventionally it is assumed that chaotropic solutes decrease the net hydrophobic 
effect of hydrophobic regions because of the disordering of water molecules  
Table 1.7 Overview of previous studies on directed evolution of subtilisin E. 
Strategy  Change in property Reference 
Error-prone PCR 
Activity increased up to 170-fold in dimethyl 
formamide (DMF) 
[41] 
Error-prone PCR 
Activity increased up to 500-fold in dimethyl 
formamide (DMF) 
[36] 
StEP combination t1/2 increased up to 50-fold at 65°C [37] 
Random-priming t1/2 increase up to 8-fold at 65°C [38] 
Error-prone 
PCRDNA shuffling 
Increased activity at different temperature and 
17°C rise in Tm 
[39] 
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surrounding the protein. This solubilization of the hydrophobic region results in the 
denaturation of the protein. It is reported such application in the hydrophobic region in 
lipid bilayers: when a critical concentration of a chaotropic solute is reached, 
membrane integrity will be compromised, and the cell will lyse [42]. Therefore it is the 
reason for its application for cell lysis in diagnostic industry.   
    Chaotropic agents include some organic solvents, like butanol, ethanol, propanol, 
some salts, like guanidinium chloride (GdmCl), magnesium chloride (MgCl2), lithium 
perchlorate (LiClO4); detergents, like sodium dodecyl sulfate (SDS) and other organic 
compound like urea ((NH2)2CO). This dissertation focuses on chaotropic salts or 
detergents, where GdmCl and SDS were selected as representatives for both classes 
due to their wide usage in academic and industrial applications. 
1.3.1.1 Chaotropic salts 
In general, salts can be either chaotropes or kosmotropes (structure-maker, opposite 
from chaotropes), depending on their specific ion effects, which are well known as 
“Hofmeister Series” [43]. In the past, the mechanism of protein denaturation by 
chaotropic salt like GdmCl was proposed that they perturbed the water’s bulk 
structure, destabilizing the protein fold. However, further studies imply that such 
denaturants exert their influence through direct interaction with the protein, not by 
restricting the bulk water, though it is still being debated [44]. The effects of ionic 
kosmotropes are usually related to the directed and polarized arrangements of 
surrounding water molecules. However, large single charged ions, with low charge 
density, such as SCN-, H2PO4
-, HSO4
-, HCO3
-, I-, Cl-, NO3
-, NH4
+, Cs+, K+, (NH2)3C
+ 
(guanidinium) and (CH3)4N
+ (tetramethylammonium) ions, exhibiting weaker 
interactions with water than water with itself and therefore interfering little in the 
hydrogen bonding of the surrounding water molecules, are chaotropes. However, 
small or multiply-charged ions, with high charge density, are kosmotropes, such as 
SO4
2-, HPO4
2-, Mg2+, Ca2+, Li+, Na+, H+, OH- and HPO4
2-, exhibiting stronger 
interactions with water molecules than water with itself and thus capable of breaking 
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water-water hydrogen bonds. Furthermore, neutron diffraction studies on a very 
effective chaotropic salt (guanidinium thiocyanate, GdmSCN) showed very poor 
hydration of both Gdm+ and SCN-, supporting the suggestion that they preferentially 
interact with the protein rather than the water [45]. 
 
Figure 1.8 Structure of guanidinium chloride (GdmCl) 
In case of GdmCl, guanidinium [46] (see Figure 1.8) is a planar ion that can form weak 
hydrogen bonds around its edge but may form strongly hydrogen-bonded ion pairs to 
protein carboxylate groups. Also, guanidinium possesses rather hydrophobic surfaces 
that may interact with similar protein surfaces to enable protein denaturation [47]. The 
hydration of the counterion is also important to the action of guanidinium with chloride 
ions, which is only weakly hydrated, allowing the water molecules to easily rearrange 
around the surface and allowing the denaturation process. However, sulfate ions trap 
their water molecules very strongly and prevent the water rearrangement and thus 
prevent the guanidinium-protein interactions and consequent denaturation [48]. 
1.3.1.2 Chaotropic detergents 
Detergent usually refers to a surfactant or a mixture of surfactants with “cleaning 
properties”, which can classify ionic detergents (like SDS) and non-ionic detergents 
(like Tween series). This dissertation is only focused on ionic detergent SDS.  
    At high enough aqueous concentrations of surfactant (the critical micelle 
concentration or CMC), it becomes favorable for the surfactant molecules to associate 
via their hydrophobic chains to form micelles with a generally hydrophobic interior and 
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a hydrophilic water-exposed exterior (see Figure 1.9). The CMC is the most important 
characteristic of a surfactant, because proteins interact very differently with 
monomeric and micellar surfactants. The CMC value of certain surfactant can 
determined by many different methods [49] and is affected by ionic strength, since the 
increase in ionic strength could reduce the electrostatic repulsion between the ionic 
head groups. For instance, CMC of SDS in water is around 7 mM, but 1-2 mM in 25 
mM Tris at pH 8 [50]. 
 
Figure 1.9 Space filling models of β-D-octyl glucoside micelles: A) classic representation 
based on 6-monomer; B) 20-monomer micelle; C) 50-monomer micelle. The micelles shown in 
B) and C) have nonspherical and nonuniform shapes. The polar portions of the detergents 
(oxygen atoms are red; carbon atoms, gray) do not cover completely the micelle surface. 
Substantial portions of the core are exposed to bulk solvent, including alkyl chains lying along 
the micelle surface (arrowheads) 
[51]
.  
    SDS is a very common used anionic surfactant in biochemistry. Its anion dodecyl 
sulfate is an amphiphilic molecule, consisting of a hydrophilic sulfate head group and 
a hydrophobic alkyl tail group. Different from other chaotropes such as GdmCl or urea, 
SDS is almost 1,000 fold more effective in protein denaturation, since it causes 
protein denaturation at a very low concentration in a millimolar range and often below 
its CMC, whereas a molar range of GdmCl or urea usually has such effect.  
    The protein-surfactant interaction has been studied for decades and many 
models were proposed, as summarized in a recent review [52]. A simple model for ionic 
surfactant like SDS is an “electrostatic-hydrophobic binding and denaturation” model, 
which means that hydrophilic head groups have electrostatic interactions with 
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charged residues (for DS- with Arg, Lys) and hydrophobic tails have interactions with 
hydrophobic areas of a protein.  
    Regarding steps in protein-surfactant interactions can normally be split into two 
parts: below and above the CMC. Bhuyan concluded that tertiary structures unfold in 
the submicellar, and chain expands in the micellar range of SDS concentration. They 
are the two major and discrete events in the perturbation of protein structure [53]. 
However, in contrast to the random coil observed in GdmCl or urea, SDS-denatured 
proteins retain a large degree of ordered structure, albeit non-native stabilized by the 
SDS molecules.  
    Besides of its denaturation effects, surfactants like SDS can also activate or 
inhibit a protein. SDS is an activator of a β-glycosidase from Sulfolobus solfataricus [54]; 
this β-galactosidase is slightly activated by 35-70 mM SDS but inactivated at higher  
concentrations (350 mM) [55]. As an enzymatic inhibitor, there are also many examples, 
targeting α-chymotrypsin [56] as noncompetitive inhibitor, amino acid oxidase as mixed 
inhibitor [57], and also reducing enzymatic activity of the fatty acid synthase [58] and 
α-glucosidase [59]. These effects take place at concentrations well below those where 
conformational changes and loss of native structure occur, indicating that SDS binds 
as a ligand rather than a self-assembling and denaturing agent. 
1.3.1.3 Application of Chaotropes 
Chaotropic salts and detergents, such as GdmCl or SDS are widely used in routine 
biochemistry laboratory. For instance, 6 M GdmCl or 8 M urea is used as strong 
denaturant for studying protein unfolding. SDS is quite often used in SDS-PAGE for 
estimation of the protein molecular weight and for studying membrane associated 
proteins.  
    Besides, these denaturants also have niche markets in diagnostic application, 
such as nucleic acid purification. For instance, it is necessary during cell disruption to 
immediately inactivate released nucleolytic enzymes, like ubiquitous RNases. Thus, 
mainly strong chaotropic salts, such as guanidinium chloride (GdmCl) or guanidinium 
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thiocyanate (GdmSCN), are utilized in high concentration [60]. In addition, some 
detergents such as SDS and Tween 20 are also supplemented for cell lysis.  
1.3.2 Chaotolerant proteases 
Chaophiles (chaophilic microbes), were proposed not long ago as a new class of 
extremophilic microbes that prefer chaotropic conditions [61]. Hence “chaophilic” or 
“chaotolerant” proteases here are labeled as proteases that prefer or tolerate 
chaotropic conditions. Halophilic and thermophilic proteases are the natural first 
choice for applications with chaotropic conditions, especially in the case of chaotropic 
salts such as GdmCl. Halophilic proteases have been mainly reported from archaea 
[62] and less frequently from bacteria [63]. Halophilic proteases often preserve high 
activity, solubility, and stability in the presence of high salt concentrations (up to 4 M); 
however, they are often denatured by GdmCl at concentrations above 3 M [64]. One 
hyperthermophilic protease, the recently discovered Tk-subtilisin from Thermococcus 
kodakaraensis seems to be most chaotolerant protease to our knowledge, as it 
retains full activity at up to 6 M GdmCl and 5 % SDS (at 55oC) [65]. However, it seems 
that it only retains its high activity and resistance towards these denaturants at its 
optimal high temperature and directed evolution has been applied for low temperature 
adaption resulting in a more rapid maturing mutant [66]. Besides, it is demonstrated 
that it requires Ca2+ for folding rather than propeptide, which are required for other 
subtilisin family members. However, Ca2+ binding in Tk-subtilisin does not seriously 
contribute to the stabilization in a native structure, and thus it is also not the same as 
other subtilisins [67]. Protease K was considered as another chaotropic protease, since 
activities assay showed stimulation by chaotropic agents like urea and GdmCl in a 
proportional manner [68], but studies showed apparent activation of proteinase K by 
urea and dodecylsulfate which was caused primarily by denaturation of the complex 
protein substrates. When a peptide substrate was applied, the residual activity of 
protease K was dramatically decreased (18 % residual activity remained in 0.5 % SDS 
on substrate Z-(Ala)2-Nan) 
[69]. 
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    In application of nucleic acid purification by chaotropic salts and detergents (see 
1.3.1.3), protease K has been supplemented to completely prevent degradation of 
nucleic acids through digestion of nucleolytic enzymes. Nevertheless the options are 
quite limited and performance is not satisfactory [70]. Additionally, understanding the 
principles that control the activity and stability of proteases [10] in chaotropic salts and 
detergents is a poorly explored research area, despite its significance in applications 
(e.g. diagnostic kits). Only one rational design study (cutinase resistance) against a 
specific anionic detergent (dioctyl sulfosuccinate sodium salt, AOT) has been reported; 
the authors postulated that surface substitutions are the main contributors to 
detergent tolerance in cutinase [71]. No protein engineering study has hitherto been 
published that used directed protease evolution with the chaotropes GdmCl and SDS.  
1.4 Computational simulations of chaotropes 
To date, a variety of molecular dynamics (MD) simulations of chaotropes, like urea, 
GdmCl or SDS have been carried out, and many different claims have been made by 
different research groups based on their analysis of a large variety of data obtained 
from these computational simulations, such as solvation of hydrophobic groups, 
dewetting effects, etc. This diversity in the conclusions might be consequence of the 
approximation of the force fields used to describe the interaction of the chaotropic 
solutes with water and proteins models. Moreover, the length of these simulation 
studies might be also a limitation of the proper simulation of process that might occur 
on larger time scale. Different observations and conclusions for chaotrope simulations 
were compared and reviewed recently [44]. 
1.4.1 Simulations on GdmCl 
Table 1.10 summarizes recent MD simulations of peptides and proteins in the 
presence of GdmCl. These simulations are very often compared to the ones in urea, 
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Table 1.10 Overview of published molecular dynamics simulations on GdmCl 
Year Simulations Force field Temperature Time Concentration Details Reference 
2004 GdmCl 
in water 
CHARMM22 300K 800 ps 3 M 31.7894 Å box containing 48 GdmCl units in 
882 TIP3P water molecules  
[47] 
2007 α-Helix (H1)  
in GdmCl 
CHARMM22 300K 25-40 ns 3.05 M 102 Gdm
+
 molecules, 100 Cl
-
 ions and 1441 
TIP3P water molecules were used in a cubic 
box ~ 32 Å per side. 
[72] 
2007 Melittin 
in GdmCl 
CHARMM22 300K 8 ns 3 M 44.7 Å cube containing 125 GdmCl units, one 
melittin, 6 Cl
-
 counterions, and 2319 TIP3P 
waters. 
[73] 
2008 Protein L 
in GdmCl 
GROMOS96 300K 
400K 
480K 
10 ns 
20 ns 
30 ns 
5 M ~100 nm
3
 dodecahedron box, SPC water 
model, one Protein L  
[74] 
2009 Isopropanol 
or pyridine in 
GdmCl 
CHARMM22 300K 10 ns 3 M 36 Gdm
+
, 36 Cl
-
 and 36 pyridine or isopropanol 
in a cubic box of length 34 Å. TIP3P water 
model was used. 
[75] 
2010 Polymer  
in GdmCl 
Amber 300K 20x5 ns 4.9 M A cubic box of length ~5 nm. SPC/E model of 
water, OPLS model for the guanidinium ion 
were used  
[76] 
2010 Magainin 
in GdmCl 
GROMOS96 300K 40 ns 1, 2, 4, 6 M Cubic box, SPC water model, one Magainin  [77] 
2012 Nanoparticle 
C60 in 
GdmCl 
Amber(ff03) 300K 10 ns 4 M The topology of Gdm
+
 was adopted from 
arginine force field. TIP3P water model was 
used. 
[78] 
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another classic chaotrope, for which a greater number of simulation studies are 
available. Simulation studies of urea-induced unfolding of larger proteins (>100 aa), 
such as barnase [79], lysozyme [80] and β-lactoglobulin [81] have been performed on time 
scale up to microsecond, but, to the best of our knowledge, so far only the small 
protein L consisting of 62 amino acids [74] has been studied and for less than 50 
nanosecond (see Table 1.10). Based on the combination of these theoretical 
simulations and experimental data, a 2-stage urea unfolding mechanism of large 
proteins has been proposed. [80]. In the first stage, the concentration of urea molecules 
increases in the vicinity of the protein surface. In this way, urea molecules solvate the 
protein surface by replacing water molecules. In the second stage, urea molecules 
start to penetrate the interior of the protein, forming hydrogen bonds with backbone 
atoms and breaking hydrophobic interactions. Differently from urea, the mechanism of 
unfolding of large protein by GdmCl to date is still unclear. 
    In 2004, Philip Mason and coworkers studied firstly the structure of aqueous 
guanidinium chloride solutions by neutron diffraction with isotopic substitution (NDIS) 
and MD simulations [47]. The force field for the guanidinium ion was based on the 
parameter used for the guanidinium group of arginine side chain in the CHARMM22 
force field. In this way, the atomic partial charges assigned symmetrically (atom 
charged: C 0.64; N -0.80; H 0.46). The analysis of anisotropic distribution of water 
atoms around the Gdm+ solute revealed a strong tendency for the water molecules to 
make linear hydrogen bonds as acceptors for the guanidinium hydrogen atoms and 
strongly constrained to remain in the plane of the Gdm+ ions. Another observation 
revealed by simulation is that the significant tendency for the Gdm+ ions to 
self-associate in a stacking fashion, while a considerable numbers of guanidinium 
ions assemble into dimers or tetramers during simulations. Additionally, this stacking 
mode of guanidinium ions was also observed in the interaction of arginine side chains 
from a simulation of a model helical peptide Melittin in 3 M GdmCl [73] and in 
simulations of a bulky nanoparticle C60 in 4 M GdmCl 
[78]. 
    Another observation revealed by MD simulations on GdmCl solution is that Gdm+ 
ion has preferential interactions with aromatic groups over aliphatic groups [75]. Philip 
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Mason investigated the structuring of isopropanol and pyridine in 3 M GdmCl and 
found that addition of 3 M GdmCl considerably reduced pyridine aggregation but had 
no effect on isopropanol aggregation, indicating that Gdm+ interacts with the planar 
pyridine group through hydrophobic interaction to suppress pyridine-pyridine 
interactions in solution. Hydrophobic interactions involving the aliphatic groups of 
isopropanol were unaffected by GdmCl, indicating that the planar and weakly 
hydrated Gdm+ cation cannot make productive interactions with the highly curved or 
“lumpy” aliphatic groups of this solute. Same observations in other simulations were 
also reported [73, 77] regardless of different force fields they applied. 
 
Figure 1.11 Snapshots of the unfolding of Protein L at 400K in 5 M GdmCl 
[74]
. It is observed 
that the α-helix degrades first (within 5 ns) prior to β-sheet along 15 ns simulation. 
    The unfolding of peptides or proteins was also observed especially when the 
temperature is elevated. For instance, in the case of protein L (see Figure 1.11), the 
destabilization of α-helix prior to β-sheet in the presence of 5 M GdmCl at 400 K or 
480 K were observed [74]. The unfolding of a peptide magainin at different 
concentrations of GdmCl revealed in lower concentrations of GdmCl (1 M and 2 M), 
that GdmCl molecules tend to engage in transient stacking interactions with aromatics 
and hydrophobic planar side chains. The latter can lead to displacement of water from 
the hydration surface and prevent proper solvation of the peptide at the beginning. In 
higher concentrations of GdmCl (>3 M), water solvates the peptide better than 1 M 
and 2 M GdmCl. Therefore, the results strongly suggest that hydrogen bonds between 
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water and the peptide are important factors in the destabilization of peptide in GdmCl 
solutions [77]. 
1.4.2 Simulations on SDS 
Several molecular dynamics (MD) simulations have been performed to study the 
various aspects of SDS micelles, such as structure [82], behavior with the solvent water 
[83], free energy of micelle formation and size distribution [84], size effects on stability [85], 
surface structure [86], and self-assembly [87]. Besides of these atomistic simulations, a 
coarse-grained (CG) model of SDS micelles has been also proposed. This simplified 
model allow the simulation of significantly large systems (as the micelles) for long time 
scale (microseconds) [88]. 
    These SDS models have been used to perform MD simulations on peptides or 
proteins in micelles at both atomistic and coarse-grained level. In these studies, the 
SDS micelle was considered as a simplified model of the biological membrane 
environment.  
    Rosemary and coworkers reported MD simulations of SDS micelle formation 
around dimeric glycophorin A (GpA) transmembrane helices to provide a detailed 
atomistic-level picture of conformation and dynamics of GpA-SDS system [89]. It was 
observed that the formation of a complete micelle around wild type GpA from an 
initially random place of SDS molecules in an aqueous solution. Additionally, the initial 
instability of GpA helices in water is reversed upon the coating of the helices by SDS. 
    Antimicrobial peptides (AMP), ovispirin-1 and its two analogs (G10 and T7) in 
SDS micelles were also studied by MD simulations by Khandelia and coworkers [90]. In 
the simulations, ovispirin, which was initially placed along the diameter of the SDS 
micelle, diffuses out of the micelle and keeps bound to the water-SDS interface. The 
final conformation and the structure of ovispirin are in a good agreement with 
experimental data in presence of lipid bilayers. Additionally, the simulations of two 
mutant peptides clarified the structural and binding properties which accounted for 
their less toxicity when compared to ovispirin.[90]. 
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    Simulation of one HIV-1 fusion peptide was also studied in SDS micelles [91]. At 
equilibrium, the peptide exhibited more flexible conformations at the N- and the C- 
terminus. The peptide with hydrophobic residues at the surface of the micelle could 
interact with the micelle’s core. The primary hydrophobic interactions with the micelles 
are from the Leu and Phe residues, while the Ala and Gly residues interact favorably 
with water molecules. The results suggest that Phe-8, one of the highly conserved 
residues of the fusion peptide, plays a key role in the interaction of the peptide with 
membranes. This simulation provided atomistic details that explain their previous 
experimental findings such as NMR and fluorescent measurement.   
Figure 1.12 Formulation of the peptide-SDS complex. Snapshots from the atomistic simulation 
(top) and coarse-grained simulation (bottom) are shown at different time 
[92]
. The main micelle 
(38 molecules) is formed in atomistic simulation. In the coarse-grained simulation, a complete 
micelle with 60 SDS molecules is formed around the peptide. The C-terminal (28-40) amino 
acids of the peptide are in dark blue. 
    Recently, MD simulations in both atomistic and coarse grain level of the 
Alzheimer’s Aβ40 peptide in SDS micelles were reported [92]. The results showed that 
the experimental conformation of the peptide in SDS micelles is well reproduced using 
atomistic MD simulations, but the position of peptide relative to the micelle was shown 
to depend on the initial conditions most probably due to the limit of simulation time (50 
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ns). Coarse grained simulations in spite of its limitation in resolving atomistic details or 
secondary structure change were performed to clarify this discordance by extension 
of simulation time scale (500-1000 ns). Comparison of both atomistic and CG 
simulations showed that the used model is sufficient for protein-surfactant systems 
and could be used for more complex system. Figure 1.12 displayed the formation of 
the peptide-SDS complex in both atomistic and coarse-grained simulation in this 
report.  
1.5 Objective of the project 
The main objective of this project is to develop proteases which could tolerate high 
concentration of chaotropic salts and/or detergents by using directed evolution 
approach and understand the structure-function relationship of such chaotolerance 
with assistance of computational analyses.  
    The outcome of this project will be beneficial both in scientific research and 
industrial application. First of all, this project will provide one useful screening method 
for directed evolution of proteases towards chaotropic salts and detergents, which are 
web transferable to other proteases and chaotropes. Secondly, some promising 
variants with improved tolerance would be obtained, followed by intensive analyses 
on a structure-function relationship to shed the light on the protein-solvent interactions, 
especially under chaotropic conditions. Additionally, it could also elucidate the change 
of specific residues which govern protease chaotolerance. Computational analysis 
assists in first hypothesis to explain subtilisin E chaotolerance and last but not least, 
the promising protease variants will be applied into a new nucleic acid purification kit 
for commercial applications.
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2. Materials and Methods 
In this chapter, biological materials and methods related to this dissertation are listed. 
There are many molecular biology methods mentioned here as well. Some are 
conventional, such as error-prone PCR (epPCR), circular dichroism (CD) spectra, etc, 
but some are relatively novel, such as Sequence Saturation Mutagenesis (SeSaM) for 
generation of less-biased and transversion-enhanced mutant libraries and 
Phosphorothiated-based ligase-independent gene cloning (PLICing) for making 
generation of mutant libraries much easier. A novel combinatorial mutagenesis 
method “SeSaM-based shuffling” was also developed. These new methods were 
initially developed by author and/or coworkers, and the protocols were adjusted 
specifically to apply to this project. 
2.1 Materials 
2.1.1 Chemicals 
All chemicals were of analytical reagent grade or higher quality and were purchased 
from Merck, Fluka, Sigma-Aldrich, and Applichem (Darmstadt, Germany), except the 
resins for purification (TOSOH, Stuttgart, Germany). All enzymes were purchased 
from New England Biolabs, Fermentas, and Sigma-Aldrich, unless otherwise stated. 
The fluorescent substrate Succinyl-Ala-Ala-Pro-Phe-7-amino-4-methylcoumarin 
(Suc-AAPF-AMC) was purchased from Bachem AG (Bubendorf, Switzerland), and 
Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Suc-AAPF-pNA) and Azocasein were 
purchased from Sigma-Aldrich.  
2.1.2 Strains 
The bacteria strains used in this work are listed in Table 2.1.  
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Table 2.1 Summary of bacteria strains used in this work 
Strain Description Reference 
Escherichia coli 
DH5α 
F'/endA1 hsdR17(rK-mK+) supE44 thi-1 recA1 gyrA 
(Nalr) relA1 D(laclZYA-argF)U169 deoR 
(F80dlacD(lacZ)M15) 
Stratagene 
 
   
Bacillus subtilis 
WB600 
nprE nprB aprE epr mpr bpr [93] 
2.1.3 Plasmids 
The plasmids used in this work are listed in Table 2.2. 
Table 2.2 Summary of plasmids used in this work 
Plasmid Description Reference 
pHY300PLK E.coli (Ap
r
) and B. sutbitlis (Tc
r
) shuttle vector, 
empty vector 
TaKaRa 
pBE3* E.coli (Ap
r
) and B. sutbitlis (Tc
r
) shuttle vector 
with subE natural promoter and gene 
[94] 
pPCRscipt_aprE vector (Ap
r
) with synthetic subE gene (inner 
Nde I restriction site eliminated) 
Synthetic 
pMA-aprE(M14) vector (Ap
r
) with synthetic subE gene with all 
14 mutations 
Synthetic 
pHY300PLK-aprE(epPCR1) selected vectors with subE gene mutant after 
1
st
 round of epPCR  
This work 
pHY300PLK-aprE(epPCR2) selected vectors with subE gene mutant after 
2
nd
 round of epPCR 
This work 
pHY300PLK-aprE(SeSaM1) selected vectors with subE gene mutant after 
1
st
 round of SeSaM 
This work 
pHY300PLK-aprE(SSM1) SSM of subE at position 1 This work 
pHY300PLK-aprE(SSM62) SSM of subE at position 62 This work 
pHY300PLK-aprE(SSM97) SSM of subE at position 97 This work 
pHY300PLK-aprE(SSM103) SSM of subE at position 103 This work 
pHY300PLK-aprE(SSM149) SSM of subE at position 149 This work 
pHY300PLK-aprE(SSM153) SSM of subE at position 153 This work 
pHY300PLK-aprE(SSM166) SSM of subE at position 166 This work 
pHY300PLK-aprE(SSM181) SSM of subE at position 181 This work 
pHY300PLK-aprE(SSM184) SSM of subE at position 184 This work 
pHY300PLK-aprE(SSM205) SSM of subE at position 205 This work 
pHY300PLK-aprE(SSM218) SSM of subE at position 218 This work 
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pHY300PLK-aprE(SSM224) SSM of subE at position 224 This work 
pHY300PLK-aprE(SSM232) SSM of subE at position 232 This work 
pHY300PLK-aprE(SSM240) SSM of subE at position 240 This work 
pHY300PLK-aprE(A153V) subE A153V mutant This work 
pHY300PLK-aprE(I205V) subE I205V mutant This work 
pHY300PLK-aprE(T240S) subE T240S mutant This work 
pHY300PLK-aprE(M2) subE mutant M2 (S62I/G166M)  This work 
pHY300PLK-aprE(M4) subE mutant SeSaM1-5 (M4, 
S62I/A153V/G166S/I205V)  
This work 
pHY300PLK-aprE(M5) subE mutant M5 
(S62I/A153V/G166S/T224A/T240S)  
This work 
pHY300PLK-aprE(M6) subE mutant M6 
(S62I/A153V/G166S/I205V/N218S/T224A)  
This work 
* This donated plasmid contains mutations in subtilisin E gene region. 
2.1.4 Oligonucleotides 
The primers used in this work are listed in Table 2.3. 
Table 2.3 Summary of oligonucleotides used in this work 
Name Sequence (5’ to 3’) Target 
ZW_LIC_gFP A*T*C*C*G*A*G*C*G*T*T*G*CATATGTGGAAGAAGATCATATTG
CACATGAA (Nde I) 
aprE 
ZW_LIC_gRP C*T*G*C*A*G*G*T*C*G*A*C*GGATCCTTATTGTGCAGCTGCTT
GTACGTTGAT (BamH I) 
aprE  
ZW_LIC_pFP C*A*A*C*G*C*T*C*G*G*A*T*CTTTTTTCAATTCTTTTACAGCT pHY300P
LK 
ZW_LIC_pRP G*T*C*G*A*C*C*T*G*C*A*G*ATCTCTAGAAGCTTGGGCAAAGC pHY300P
LK 
SeSaM_fwd_ZW_gF CACACTACCGCACTCCGTCGATCCGAGCGTTGCATATGTGGA
AGAAG (Nde I) 
aprE 
SeSaM_rev_ZW_gR GTGTGATGGCGTGAGGCAGCCTGCAGGTCGACGGATCCTTAT
TGTG (BamH I) 
aprE  
SeSaM_up_ZW_gF CGCCTGTCACATCCGAGCGTTGCATATGTGGAAGAAG (Nde I) aprE 
SeSaM_dn_ZW_gR GCGGACAGTGCTGCAGGTCGACGGATCCTTATTGTG (BamH I) aprE  
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ZW_FW_SSM1 5’-CCATACCAGGACGGCNNKTCTCACGGTACGCAT-3’ A1 
ZW_RV_SSM1 5’-ATGCGTACCGTGAGAMNNGCCGTCCTGGTATGG-3’ A1 
ZW_FW_SSM62 5’-CCATACCAGGACGGCNNKTCTCACGGTACGCAT-3’ S62 
ZW_RV_SSM62 5’-ATGCGTACCGTGAGAMNNGCCGTCCTGGTATGG-3 S62 
ZW_FW_SSM97 5’-GCAGTAAAAGTGCTTNNKTCAACAGGAAGCGGC-3’ D97 
ZW_RV_SSM97 5’-GCCGCTTCCTGTTGAMNNAAGCACTTTTACTGC-3’ D97 
ZW_FW_SSM103 5’-TCAACAGGAAGCGGCNNKTATAGCTGGATTATT-3’ Q103 
ZW_RV_SSM103 5’-AATAATCCAGCTATAMNNGCCGCTTCCTGTTGA-3’ Q103 
ZW_FW_SSM149 5’- TCCAGCGGTATCGTCNNKGCTGCCGCAGCCGGA -3’ V149 
ZW_RV_SSM149 5’-TCCGGCTGCGGCAGCMNNGACGATACCGCTGGA-3’ V149 
ZW_FW_SSM153 5’- GTCGTTGCTGCCGCANNKGGAAACGAAGGTTCA -3’ A153 
ZW_RV_SSM153 5’- TGAACCTTCGTTTCCMNNTGCGGCAGCAACGAC -3’ A153 
ZW_FW_SSM166 5’-AGCACAAGCACAGTCNNKTACCCTGCAAAATAT-3’ G166 
ZW_RV_SSM166 5’-ATATTTTGCAGGGTAMNNGACTGTGCTTGTGCT-3’ G166 
ZW_FW_SSM181 5’-GCAGTAGGTGCGGTANNKAGCAGCAACCAAAGA-3’ N181 
ZW_RV_SSM181 5’-TCTTTGGTTGCTGCTMNNTACCGCACCTACTGC-3’ N181 
ZW_FW_SSM184 5’-GCGGTAAACAGCAGCNNKCAAAGAGCTTCATTC-3’ N184 
ZW_RV_SSM184 5’-GAATGAAGCTCTTTGMNNGCTGCTGTTTACCGC-3 N184 
ZW_FW_SSM205 5’-GCTCCTGGCGTGTCCNNKCAAAGCACACTTCCT-3’ I205 
ZW_RV_SSM205 5’-AGGAAGTGTGCTTTGMNNGGACACGCCAGGAGC-3’ I205 
ZW_FW_SSM218 5’- ACTTACGGCGCTTATNNKGGAACGTCCATGGCG-3’ N218 
ZW_RV_SSM218 5’- CGCCATGGACGTTCCMNNATAAGCGCCGTAAGT-3’ N218 
ZW_FW_SSM224 5’- GGAACGTCCATGGCGNNKCCTCACGTTGCCGGA-3’ T224 
ZW_RV_SSM224 5’- TCCGGCAACGTGAGGMNNCGCCATGGACGTTCC-3’ T224 
ZW_FW_SSM232 5’- GTTGCCGGAGCAGCANNKTTAATTCTTTCTAAG -3’ A232 
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ZW_RV_SSM232 5’- CTTAGAAAGAATTAAMNNTGCTGCTCCGGCAAC -3 A232 
ZW_FW_SSM240 5’-CTTTCTAAGCACCCGNNKTGGACAAACGCGCAA-3’ T240 
ZW_RV_SSM240 5’-TTGCGCGTTTGTCCAMNNCGGGTGCTTAGAAAG-3’ T240 
ZW_FW_A153V 5’- GTCGTTGCTGCCGCAGTCGGAAACGAAGGTTCA -3’ A153V 
ZW_RV_A153V 5’- TGAACCTTCGTTTCCGACTGCGGCAGCAACGAC -3’ A153V 
ZW_FW_G166M 5’-AGCACAAGCACAGTCATGTACCCTGCAAAATAT-3’ G166M 
ZW_RV_G166M 5’-ATATTTTGCAGGGTACATGACTGTGCTTGTGCT-3’ G166M 
ZW_FW_I205V 5’-GCTCCTGGCGTGTCCGTCCAAAGCACACTTCCT-3’ I205V 
ZW_RV_I205V 5’-AGGAAGTGTGCTTTGGACGGACACGCCAGGAGC-3’ I205V 
ZW_FW_S62I 5’-CCATACCAGGACGGCATCTCTCACGGTACGCAT-3’ S62I 
ZW_RV_S62I 5’-ATGCGTACCGTGAGAGATGCCGTCCTGGTATGG-3’ S62I 
ZW_FW_S85A 5’- GGTGTTCTGGGCGTTGCGCCAAGCGCATCATTA-3’ S85A 
ZW_RV_S85A 5’-TAATGATGCGCTTGGCGCAACGCCCAGAACACC-3 S85A 
ZW_FW_D97A 5’-GCAGTAAAAGTGCTTGCTTCAACAGGAAGCGGC-3’ D97A 
ZW_RV_D97A 5’-GCCGCTTCCTGTTGAAGCAAGCACTTTTACTGC-3’ D97A 
ZW_FW_T240S 5’-CTTTCTAAGCACCCGAGTTGGACAAACGCGCAA-3’ T240S 
ZW_RV_T240S 5’-TTGCGCGTTTGTCCAACTCGGGTGCTTAGAAAG-3’ T240S 
* indicates phosphorothioate (PTO) attached. Underlined sequences indicate the restriction sites, and 
letters in bold indicate the codons targeted for site directed mutagenesis (SDM).  
2.1.5 Media and culture cultivation 
E. coli cells were routinely cultivated in Luria broth (LB) medium supplemented with 
appropriate antibiotics (Amp: 100 µg·mL-1) using a shaking incubator (Multitron II, 
Infors GmbH, Einsbach, Germany) at 37°C, 250 rpm for 12~16 h, while B. subtilis 
cells were cultivated in the same medium supplemented with appropriate antibiotics 
(Tet: 15 µg·mL-1) under the same conditions for 24 h (test tubes) or 36 h (flasks).  
    Active colonies which showed halos when grown on LBtet agar plates with skim 
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milk (1 %) as substrate were transferred by toothpicks into 96-well microtiter plates 
(V-bottomed, polystyrene plates; Greiner Bio-One GmbH, Frickenhausen, Germany) 
containing LB medium (150 µL) supplemented with tetracycline (15 µg·mL-1 per well). 
After 16 h of cultivation in a Multitron II microtiter plate shaker (Infors GmbH, Einsbach, 
Germany; 37°C, 900 rpm, 70 % humidity), each 96-well microtiter plate was replicated 
(replicator tool; Enzy-Screen BV, Leiden, Netherland) into a 96-well microtiter plate 
containing the same medium, and cultivated in LBtet medium in a Multitron II microtiter 
plate shaker (24 h, 37°C, 900 rpm, 70 % humidity; Infors). Subtilisin E and variants 
were constitutively expressed and the cell cultures from microtiter plates were 
centrifuged (3,220 g, 4°C, 20 min). The supernatants were directly used for screening. 
2.2 Methods 
2.2.1 General methods 
2.2.1.1 PCR reactions 
A thermal cycler (Mastercycler gradient; Eppendorf) and thin-walled PCR tubes (0.2 
mL Multi-ultra tubes; Carl Roth, Germany) were used in all PCR reactions. The PCR 
volume was always 50 mL except otherwise stated; larger volumes were prepared as 
multiple of 50 mL PCRs. The amount of DNA in cloning experiments was quantified by 
using a NanoDrop photometer (Thermo Scientific, Wilmington, USA). 
    Colony PCR was performed with a slight modification of standard PCR using 
colony from agar plate as template. An additional 5 min as denaturing step was 
applied at beginning for colony PCR.  
2.2.1.2 Cloning 
All gene manipulation steps carried out according to molecular cloning book [95], while 
the phosphorothioate-based ligase-independent gene cloning (PLICing) method was 
applied for all gene cloning [96]. Preparation of E. coli competent cells and 
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transformation were carried out as standard heat shock transformation [97] and 
electroporation [98]. Plasmids were verified by PCR, restriction enzyme digestion and 
sequence analysis. Sequence results were analyzed by Vector NTI 9 (Invitrogen). 
Plasmid isolation kit, PCR purification kit and rolling circle amplification kit (REPLI-g 
Mini Kit) were purchased from Qiagen (Hilden, Germany).  
2.2.1.3 TCA precipitation and SDS-PAGE analysis 
TCA precipitation and SDS-PAGE analysis of proteins were carried out according to 
described standard protocol [95].  
2.2.1.4 Protein quantification 
Protein concentration and purity were determined using automated electrophoresis by 
an Agilent 2100 Bioanalyzer (Agilent Protein 230 Kit; Agilent Technologies, Bölingen, 
Germany) or Experion microfluidic system (Bio-Rad, CA) and the BCA protein assay 
kit (no. 23225; Pierce Biotechnology, Rockford, IL) according to the manual’s 
instruction. In addition BSA (200 µg·mL-1) was used as internal standard. 
2.2.2 Construction of expression vector and strains 
The subtilisin E gene (aprE) was ordered as a synthetic gene (Geneart, Regensburg, 
Germany), cloned into the commercial shuttle vector pHY300PLK (Takara Bio Inc, 
Japan) with restriction site EcoR I and BamH I, yielding pHY-aprE and transformed 
into E. coli DH5α for storage. The constructed vector pHY-aprE was transformed after 
replication (REPLI-g Mini Kit; Qiagen, Hilden, Germany) into B. subtilis WB600 as a 
host strain for expression. 
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2.2.3 Generation of random mutagenesis libraries  
2.2.3.1 epPCR library 
The Nde I and BamH I DNA fragment of pHY-aprE encodes the mature subtilisin E 
and was selected as the template for random mutagenesis. PLICing method was 
applied for all cloning procedures [96]. Two oligonucleotides, ZW_LIC_gFP and 
ZW_LIC_gRP (see 2.1.4) were used as forward and reverse primers to amplify the 
mature subtilisin E. The error prone PCR (epPCR) libraries were generated by using 
the template (pHY-aprE, 50 ng), dNTP mix (0.2 mM), dGTP (0.2 mM), MnCl2 (0.05-0.5 
mM), Taq DNA polymerase (5 U), forward and reverse primers (20 pmol) under the 
following PCR conditions: 94oC for 2 min 1 cycle; 94 oC for 30 sec/60 oC for 1 min/72 
oC for 1 min 29 cycles; 72 oC for 5 min 1 cycle.  
    The vector fragment pHY-aprE- was amplified by using a template (pHY-aprE, 50 
ng), dNTP mix (0.2 mM), Betaine (1 M), Taq/Pfu DNA polymerase mix (4.5 U/0.072U) 
and primers ZW_LIC_pFP and ZW_LIC_pRP (see 2.1.4) under the following PCR 
conditions: 94oC for 2 min 1 cycle; 94oC for 30 sec/60oC for 30 sec/68oC for 9 min 35 
cycles; 68oC for 10 min 1 cycle. The resulting PCR products of pHY-aprE- were 
purified using a Qiagen PCR purification kit. The purified pHY-aprE- and epPCR 
products were digested by Dpn I (40 U; New England Biolabs) at 37oC overnight, 
followed by further DNA purification (Qiagen quick PCR purification kit). Both 
fragments (0.1 pmol pHY-aprE- and 0.3 pmol epPCR products) were further digested 
by iodine mixture respectively at 70oC for 10 min, and then mixed at room 
temperature for 30 min for ligation. The ligation mixture was afterwards transformed 
into E. coli DH5α and plated on LBAmp agar plates. Thousands of E. coli DH5α variants 
were harvested by resuspending in double-distilled water and subsequent plasmid 
isolation. The resultant plasmid pool was then transformed into B. subtilis WB600. 
Ten randomly picked and sequenced variants of epPCR libraries confirmed within 
statistical errors in the expected mutational bias. 
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2.2.3.2 SeSaM library 
The SeSaM [33] library was generated with the improved variants selected after two 
rounds of epPCR library screening as template. The generation of the SeSaM library 
was carried out according to the Handbook (SeSaM-Tv Classic version 0.16) provided 
by SeSaM-Biotech GmbH. PLICing method was again used for cloning. The PCR was 
carried out by using a SeSaM library as template (50 ng), dNTP mix (0.2 mM), Pfu 
DNA polymerase (2.5 U), together with forward and reverse primers (ZW_LIC_gFP 
and ZW_LIC_gRP, 20 pmol) under PCR conditions: 98oC for 30 sec 1 cycle; 98oC for 
5 sec/60oC for 15 sec/72oC for 15 sec 15 cycles; 72oC for 3 min 1 cycle. The further 
cloning was carried out according to the same procedure as previously described in 
this project. 
2.2.4 Site-directed and saturation mutagenesis 
Site directed mutagenesis (SDM) and saturation mutagenesis (SSM) of the subtilisin 
E wild type was employed to elucidate the role of each substitution identified in 
selected variants. Recombination of substitutions was performed based on different 
parents by SDM as well. In all focused mutagenesis experiments, a modified 
QuikChange method (Stratagene/Agilent Technologies) was utilized [99].  
2.2.5 SeSaM-based shuffling 
The SeSaM-based shuffling libraries were generated with both subtilsin E wild type 
and synthetic gene M14 (with 14 amino acid substitutions, sequence see Appendix I) 
as template. The generation of the SeSaM-based shuffling library was carried out 
according to the Handbook (SeSaM-Tv Classic version 0.21) provided by 
SeSaM-Biotech GmbH. However, Step 3 used two template ratios (WT/M14) of 1:1 
and 1:2, and different PCR cycles (15, 30 and 45 cycles) were also applied for 
optimization of conditions for library generation. PLICing method was again used for 
cloning in the final step as described in section 2.2.3.  
 
Chapter 2 - Materials and Methods 
33 
 
2.2.6 Agar plate assay for detection of protease activity 
LB agar plates supplemented with appropriate antibiotics and 1 % Skim milk were 
used and protease activities were detected by halo formation.  
2.2.7 MTP screening assays for activity and resistance 
towards chaotropes 
Fluorimetric microtiter plate assay: The assay was carried out in 96-well microtiter 
plates (black flat bottomed, polystyrene plates; Greiner Bio-One GmbH, 
Frickenhausen, Germany) with Suc-AAPF-AMC in Tris-HCl buffer (0.1 M, pH 8.5, 
37oC) in the presence or absence of GdmCl (1 M, final concentration) or SDS (0.5 %, 
final concentration). The cell-free supernatants (10 µL) of the subtilisin E variants 
were supplemented in Tris-HCl buffer (40 µL, 0.1 M, pH 8.5), GdmCl solution (40 µL, 
2.5 M GdmCl in 0.1 M Tris-HCl buffer, pH 8.5) and SDS solution (40 µL, 1.25 % SDS 
in 0.1 M Tris-HCl buffer, pH 8.5) respectively, incubated (25oC, 30 min), and activities 
were determined by supplementing the substrate solution (50 µL, 200 µM 
Suc-AAPF-AMC in 0.1 M Tris-HCl buffer; pH 8.5). The final reaction volume was 
always 100 µL. Calcium was not supplemented to SDS reaction assays despite its 
stabilizing function [100], since it causes precipitation. The activity in the presence or 
absence of chaotropes was measured at 37°C by monitoring the increase of 
fluorescence intensity within 20 min using the Tecan SAFIRE (Excitation: 350 nm / 
Emission: 450 nm, Tecan Austria GmbH, Salzburg, Austria). One unit of enzymatic 
activity was defined as the amount of the enzyme that produced 1 pmol of 
7-amino-4-methylcoumarin (AMC) per min. The specific activity was defined as the 
protease activity per milligram of protein. 
Skim-milk microtiter plate assay: The assay was carried out in 96-well microtiter 
plates (flat-bottomed, polystyrene plates; Greiner Bio-One GmbH, Frickenhausen, 
Germany). The screening procedure was performed by applying 10 µL cell-free 
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supernatants of subtilisin E variants in 90 µL Tris-HCl buffer (0.1 M, pH 8.5, 37oC), 
and activities were determined by supplementing the substrate solution (100 µL, 
2.0 % Skim-milk in 0.1 M Tris-HCl buffer, pH 8.5). The final reaction volume is 200 µL. 
The activity was measured at 37oC by monitoring the increase of absorbance at 580 
nm within 15 min using Tecan Sunrise (Tecan Austria GmbH, Salzburg, Austria). 
2.2.8 Purification  
Shaking flask (1 L) containing LB medium (150 mL) supplemented with tetracycline 
(15 µg·mL-1) were inoculated with 1:150 dilution of an overnight culture (B. subtilis 
WB600 harbouring pHY-aprE) grown in the same medium. After 36 h of expression, B. 
subtilis WB600 cells were harvested by centrifugation (Eppendorf 5810R, 4oC, 3,220 
g, 30 min) and the culture supernatant was cleared by filtration (0.2 µm Minisart sterile 
syringe filter; Sartorius, Goettingen, Germany). The filtered solution was subsequently 
concentrated through a 5 kDa cut-off membrane (Millipore, Billerica, MA, USA) by 
using a stirred Amicon ultrafitration cell (Millipore). Then two different methods of 
purification were applied for different variants: 
Method 1: The concentrated supernatants were transferred into a Tris-HCl buffer (0.1 
M; pH 7.5; 20 mL). Concentrated solutions of wild type subtilisin E and variants S62I, 
G166M, M2 (S62I/G166M), SeSaM1-5 (M4) were subsequently purified by ion 
exchange column chromatography: 1) Subtilisin E variants were loaded onto a 
SuperQ anion-exchange column (25 mL) equilibrated with the same buffer. Subtilisin 
E was eluted by linearly increasing the NaCl concentration from 0 to 1.0 M in the 
same buffer at a rate of 2 mL·min-1 (5 column volumes in total). 2) The obtained 
protein solution was loaded onto a SP650c cation-exchange column (25 mL) which 
was equilibrated with the same buffer. Subtilisin E was remained in the flow through 
while other proteins were bound. The SP650c cation-exchange column was 
regenerated via a NaCl gradient elution from 0 to 2.0 M (5 column volumes in total) in 
the same buffer at a rate of 3 mL· min-1. Purified subtilisin E variants were 
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subsequently concentrated in an Amicon ultra centrifugal filter device (Millipore) with a 
10 kDa cut-off membrane. 
Method 2: The concentrated supernatants were transferred into a sodium phosphate 
buffer (10 mM; pH 6.2; 15 mL). Concentrated solutions of wild type subtilisin E and 
variants N218S, T224A, SeSaM1-5 (M4) were subsequently purified by ion exchange 
column chromatography: 1) Subtilisin E variants were loaded onto a CM 
cation-exchange column (25 mL) equilibrated with the same buffer. Subtilisin E was 
eluted by linearly increasing the NaCl concentration from 0 to 0.2 M in the same buffer 
at a rate of 2 mL·min-1 (5 column volumes in total). 2) The obtained protein solution 
was collected and dialysed in 1 L Tris-HCl buffer (0.05 M; pH 8.5) at 4oC overnight. 
The dialysed solutions were then loaded onto a Super-Q anion-exchange column (25 
mL) which was equilibrated with the same Tris-HCl buffer. Subtilisin E was remained 
in the flow through while other proteins were bound. The Super-Q anion-exchange 
column was regenerated via a NaCl gradient elution from 0 to 2.0 M (5 column 
volumes in total) in the same buffer at a rate of 2 mL· min-1. Purified subtilisin E 
variants were subsequently concentrated in an Amicon ultra centrifugal filter device 
(Millipore) with a 10 kDa cut-off membrane. Variant M5 and M6, due to their poor 
binding to CM column, were purified through SuperQ column twice instead. 
2.2.9 Determination of kinetic constants 
Measurements were carried out in 96-well microtiter plates (flat-bottomed, 
polystyrene plates; Greiner Bio-One GmbH, Frickenhausen, Germany) by employing 
50 nM purified protease solution in the presence of 1 M, 2 M GdmCl, 0.5 % SDS or 
absence of chaotropes in Tris-HCl buffer (pH 8.5; 0.1 M) and varied Suc-AAPF-pNA 
concentrations (0.05 - 10.0 mM). The amount of p-nitroaniline (pNA) released from 
Suc-AAPF-pNA was determined by absorbance measurements (405 nm). One unit of 
protease activity was defined as the amount of protease that produced 1 µmol of 
p-nitroaniline per min. The specific activity was defined as the protease activity per 
milligram of protein. For kinetic analysis, kcat and Km values were determined from 
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initial velocity data measured as a function of substrate concentration with a linear 
correlation coefficient of >0.99. 
2.2.10 Inactivation curve determination 
The purified subtilisin E wild type and its variants (50 nM) were incubated at room 
temperature (25oC) for 30 min in the presence of various concentrations of GdmCl (0 - 
6.0 M) or SDS (0 - 4.0 %) in Tris-HCl buffer (pH 8.5; 0.1 M). The activities of purified 
subtilisin E wild type and its variants were determined by addition of Suc-AAPF-pNA 
(1.0 mM) as described in section 2.2.9. Relative activities were calculated as 
percentage of activities in the absence of chaotropes which was set as 100 %. Half 
life of inactivation of subtilisin E and its variants, designated as IC50, was defined as 
the chaotrope concentration at which the activity of subtilisin E remained 50 % under 
conditions mentioned previously. 
2.2.11 Stability in the presence of chaotropes 
The purified subtilisin E wild type and its variants (50 nM) were incubated at room 
temperature (25oC) in the presence of given concentrations of GdmCl or SDS. At 
different time points (0, 0.25, 0.5, 1, 2, 4, 6 and 9 h), the activities of purified subtilisin 
E wild type and its variants were determined using Suc-AAPF-pNA as described in 
section 2.2.9. Relative activities were calculated as percentage of initial activities in 
the presence and absence of chaotropes. The activity in the absence of a chaotrope 
was set as 100 %. Half life of stability of subtilisin E and its variants in terms of time, 
designated as t1/2, was defined as the time point at which the activity of subtilisin E 
remained 50 % under conditions mentioned previously (see section 2.2.9). 
2.2.12 Activity towards complex protein substrate 
The enzymatic activities of purified subtilisin E and its variants towards complex 
protein substrate were determined by using Azocasein (Sigma) and an Eppendorf 
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Thermomixer comfort (Eppendorf AG, Hamburg, Germany; 1.5 ml Eppendorf tubes, 
37oC, 500 rpm). A modified method from Pulido et al. [101] was applied. The reaction 
mixture (300 µL) contained Tris-HCl (pH 8.5; 0.1 M) and 2.0 % Azocasein. The 
enzymatic reaction was initiated by adding the purified enzyme (0.5 µM) and 
terminated by adding trichloroacetic acid (200 µL; 15 %). The reaction time was 
usually 30 min. After centrifugation (15,000 g, 15 min), an aliquot of supernatant (80 
µL) was withdrawn, mixed with NaOH (20 µL; 2 M), and measured for absorbance at 
440 nm. One unit of enzymatic activity was defined as the amount of enzyme that 
increased the A440 value of the assay reaction mixture by 0.1 in 1 min. 
2.2.13 Circular dichroism (CD) analysis 
The total sample volume was 36 μL in each measurement using 0.1 mm cuvette. 24 
μL of the sample was prepared by the respective amounts of Tris-HCl buffer (pH 8.5; 
0.1 M) and chaotrope solutions (1.5 M, 3 M, 4.5 M, 7.5 M GdmCl, 0.75 %, 1.5 %, 3.0 % 
SDS in 0.1 M Tris-HCl buffer, pH 8.5) in 0.5 mL PCR tubes. 12 μL of appropriate 
concentrated purified subtilisin E and its variants (final concentration 200-300 μg· mL-1; 
purified by Method 2 in 2.2.7) were pipetted into the same PCR tube with 
pre-prepared buffer, GdmCl (final concentration of 1 M, 2 M, 3 M and 5 M) or SDS 
(final concentration of 0.5 %, 1.0 % and 2.0 %). The mixture of enzymes and 
chaotrope solutions were gently mixed by pipetting, and immediately analyzed at 
room temperature with an Olis SDM 17 CD (Olis, Bogart, USA). 
    For each sample, five scans from 190 to 240 nm were recorded and averaged. 
210 nm was selected as a benchmarking wavelength for GdmCl since GdmCl, 
especially at high concentration, has an increased absorbance below 210 nm leading 
to high noise/signal ratios. The latter interferes with deconvolution of recorded CD 
spectra. The bandwidth was adjusted to 2 nm, the step width to 1 nm. As baseline, 
buffer and various concentrations of chaotrope solutions without subtilisin E (use 
buffer instead) were employed in all experiments to avoid deviations caused by 
different cosolvents. CD spectra were smoothed by the Savitzky-Golay filter (Olis 
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Global Works software package), and results were given as milli degrees and 
converted into mean residue ellipticity.  
2.2.14 Computational analyses 
2.2.14.1 Model building  
A crystal structure of the Pro-subtilisin E complex is available at 0.2 nm resolution 
(Protein Data Bank accession code: 1SCJ) [12]. In order to generate the structure of 
subtilisin E–Suc-AAPF-pNA complex, the pro-peptide domain of crystal structure 
subtilisin E was removed, except the four amino acids (Ala-His-Glu-Tyr) chain at 
C-terminal which binds with active site residues as enzyme-substrate complex. The 
four amino acids chain was then mutated computationally to the sequence 
Ala-Ala-Pro-Phe (AAPF) and attached to both termini using two functional groups 
n-succinyl and p-nitroanilide to form the substrate Suc-AAPF-pNA. The favourable 
rotamer was selected in all cases. Finally, the active site Cys 221 of subtilisin E was 
mutated back to the catalytic Ser residue. All amino acid exchanges were performed 
using the Model Build tool of the program Fold X [102]. Two calcium ions (named Ca1, 
Ca2) which were present in the crystal structure were retained for modelling. The final 
structures of the protein-substrate complex was subsequently energy minimized in 
vacuum using the GROMOS96 force field [103]. For models without substrate 
Suc-AAPF-pNA, the same building procedure was carried out except the complete 
removal of Pro-peptide domain. 
2.2.14.2 Docking 
AutoDock4 [104], is currently widely used for in silico protein-ligand docking. The 
programs Yasara [105] with Autodock4 were used to predict the docking structure of 
subtilisin E and GdmCl (PubChem database CID:32838) or SDS (PubChem database 
CID:4329331). The docking preparation procedure steps for the ligands were (1) 
converting the structure from sdf to pdb followed by energy minimization (2) adding 
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hydrogen atoms, and (3) determining the docking grid (5 Å extended around the 
center of selected active site and/or substrate binding pocket residues). All these 
steps could be accomplished within Yasara program.  
2.2.14.3 MD simulations of melittin  
Gromacs engine (Version 3.3.3 and 4.0.7) was used for all molecular dynamics (MD) 
simulations (see Table 2.4). In these MD simulations, a neutral periodic cubic system 
was created containing a single helical melittin molecule and a number of 
independent guanidinium and chloride ions surrounded by explicit water molecules. 
The melittin starting coordinates were taken from the Protein Data Bank (accession 
code 2MLT), removed C-terminal NH2 group and used in conjunction with the 
GROMOS96 43a1 force field parameters. Water molecules were represented using  
SPC model. The parameters of the force field concerning the GdmCl are taken from 
Camilloni and coworkers. [74].  
    Pre-generation of simulation boxes of various concentrations of GdmCl were 
performed to facilitate the setup of different MD simulations. For GdmCl, 3 M and 5 M 
boxes (gro files, cubic box with volume of 2.2 nm3) were directly taken from Camilloni 
and coworkers [74], while 1 M box was generated in the same manner using the same 
topology file (itp file). Arbitrary starting coordinates were generated by randomly 
placing and orienting one melittin molecule, 234 Gdm+/239 Cl- (5 M), or 175 Gdm+/180 
Cl- (3 M), or 51 Gdm+/56 Cl- (1 M) in a 5 nm3 cubic box. Here the total charge of the 
box (+5) was neutralized by replacing five water molecules at the most positive 
electrostatic potential with 5 Cl- ions.  
    Position restriction equilibration was preformed for 100 ps with velocity assigned 
as 0.002 ps. The simulation was then run for total 10.0 ns with no velocity 
reassignment. The first 1.0 ns of this was taken as annealing equilibration to 298 K, 
and rest 9 ns was used for analysis. MD simulation in pure water was also performed 
for comparison.  
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2.2.14.4 MD simulations of subtilisin E 
Gromacs engine (Version 3.3.3 and 4.0.7) was also used for all MD simulations on 
subtilisin E (see Table 2.4). The starting structure of the subtilisin E for MD simulations 
was prepared as described in 2.2.14.1. In this case, the Pro-peptide domain present 
in the crystal structure was completely removed, since it is cleaved in the maturation 
process. The GROMOS96 43a1 force field parameters were used for all simulations 
[103]. The water was modeled using the Simple Point Charge model [106]. The GdmCl 
model was taken from Camilloni and coworkers. [74]. For SDS model, The initial 
coordinates for the surfactant monomers were generated from ProDRG [107] and 
partial charges on the sulfate head group were adopted from Bruce and coworkers. 
[82b].  
    Pre-generated simulation boxes of various concentrations of GdmCl were also 
performed in MD simulations on subltisin E (see 2.2.14.3), as well as SDS. For SDS, 
1 % and 5 % boxes (gro files, cubic box with volume of 8.0 nm3) were generated using 
the topology file from ProDRG as mentioned above followed by energy minimization 
using the Groms96 45a1 force field.  
    The MD simulations of subtilisin E and its variants were carried out in water and 
various concentrations of GdmCl and SDS at 298 K (see Table 2.4). The simulation 
boxes were built by centering the subtilisin E molecule in a cubic box (8 nm3). 
Subtilisin E was solvated by stacking an equilibrated box of 216 water molecules to 
completely fill the simulation box. All solvent molecules with any atom within 0.15 nm 
from solute atoms were removed. 5 M GdmCl solution, for instance, was generated by 
placing 1139 Gdm+ molecules and 1141 Cl- ions in the cubic box with one subtilisin E 
molecule. 5 % SDS solution, for instance was generated by placing 32 dodecylsulfate 
ions (DS-) and 32 Na+ ions in the cubic box with one subtilisin E molecule. The water 
molecules were filled in the remaining space of the simulation box. The total charge of 
the box (+2) was neutralized by replacing two water molecules at the most positive 
electrostatic potential with two Cl- ions. Subtilisin E variant M4 in GdmCl and SDS 
were performed in the same manner. 
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Simulation protocol: Systems described in the previous paragraph were energy 
minimized using the steepest descent method for at least 500 steps to remove 
clashes caused by generated solvent molecules. Subtilisin E was finally studied at 
298 K. All simulations were performed by keeping the temperature at the reference 
values by weak coupling (coupling constant τ=0.1 ps) with an external bath [108]. The 
pressure of the system was kept constant at 1 bar by using the Berendsen barostat 
equation with a coupling constant of τp= 0.5 ps. The LINCS algorithm was used to 
constrain all bond lengths [109]. For the water molecules, the SETTLE algorithm was 
used [110]. A dielectric permittivity, r= 1, and a time step of 2 fs were used. The 
non-bonded interactions (electrostatic and Leonard-Jones) were calculated using the 
Particle Mesh Ewalds (PME) method [111]. For the calculation of the long-range 
interactions, a grid spacing of 0.12 nm combined with a fourth-order B-spline 
interpolation were used to compute the potential and forces between grid points. A 
non-bonded pair-list cut-off of 0.9 nm was used and the pair-list was updated every 5 
time steps. The MD simulations were started by assigning to all atoms initial velocities 
obtained from a Maxwellian distribution at the given temperature. The box density was 
equilibrated for 100 ps using position restraints on the protein heavy atoms. After the 
equilibration, the position restraints on the protein were removed and the system was 
gradually heated from 50 K to the simulation temperature during 50 ps of simulation 
and then hence equilibrated for 5 ns. The following production runs were 20 or 45 ns 
long. 
Analysis of trajectory: The protein structure along the two trajectories was monitored 
using standard analysis tools to assess the amount of deviations from the 
crystallographic structure and its mobility. The distribution of the guanidinium ions or 
dodecylsulfate ions around subtilisin E was analysed using the spatial distribution 
functions (SDF). The calculation of SDF was carried out on the last 25 ns of the 
simulations using a g_spatial program of the Gromacs package (4.0). The resulting 
spatial distribution function (SDF) was visualized using the program VMD [112]. 
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Besides, essential dynamics analysis [113] was also performed to clarify the subtle 
changes of protein mobility throughout the trajectory.   
Table 2.4 Overview of all MD simulations in this work 
Index Peptide or Protein Solvent Duration (ns) 
1 Melittin Water 10 
2 Melittin 1 M GdmCl 10 
3 Melittin 3 M GdmCl 10 
4 Melittin 5 M GdmCl 25 
5 Subtilisin E WT Water 50 
6 Subtilisin E WT 5 M GdmCl 50 
7 Subtilisin E M4 Water 25 
8 Subtilisin E M4 5 M GdmCl 25 
9* Subtilisin E WT Water 25 
10* Subtilisin E WT 1 M GdmCl 25 
11* Subtilisin E WT 3 M GdmCl 25 
12* Subtilisin E WT 5 M GdmCl 25 
13 Subtilisin E WT 1 % SDS 25 
14 Subtilisin E WT 5 % SDS 25 
15 Subtilisin E M4 5 % SDS 25 
 * These simulations were run after 25 ns long equilibration of subtilisin E WT in pure water.
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3. Results 
In this chapter, main results of this dissertation are presented, including three different 
subjects: 1) Directed evolution of subtilisin E for improved GdmCl and SDS tolerance; 
2) Systematic analysis of effects of substitutions identified from directed evolution 
using site directed, saturation mutagenesis and recombination; 3) Computational 
analysis of subtilisin E in the presence of GdmCl or SDS by docking and molecular 
dynamics (MD) simulations. These results revealed that several highly improved 
variants were identified after three rounds of directed evolution with respect to their 
resistance towards both GdmCl and SDS. Interestingly, most beneficial substitutions 
were located around the active site or substrate binding pockets, which are beyond 
our expectation and indicated of some important features in protein denaturation. 
Besides, computational analysis provided detailed information to understand such 
phenomena and strengthened the hypothesis in the denaturation process of proteins 
induced by GdmCl and SDS. 
3.1 Directed evolution of subtilisin E 
3.1.1 Cloning and expression of subtilisin E in B. subtilis 
For cloning and expression of the subtilisin E gene (aprE), vectors pBE3* and 
pHY300PLK, A synthetic subtilisin E gene (including pre and pro sequence) were 
used. The mature domain sequence of aprE was amplified by PCR and replaced by a 
corresponding sequence region of pBE3* into pBE3 (subtilisin E wild type). Then the 
EcoR I and BamH I digested fragment from pBE3 together with its natural promoter 
was cleaved off and cloned into a comparable small commercial shuttle vector 
pHY300PLK to construct the final expression plasmid pHY-aprE (see Figure 3.1), and 
then transformed into E. coli DH5α for storage and B. subtilis WB600 for expression 
(see Figure 3.2 A). The proteolytic activities could be easily detected from halos on 1 % 
Skim milk agar plate (see Figure 3.2 B). 
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Figure 3.1 Construction of the expression plasmid pHY300PLK-aprE. A synthetic subtilsin E 
gene (aprE, wild type) was amplified by PCR and replaced Nde I and BamH I digested 
fragment of pBE3* to construct the correct pBE3. EcoR I and BamH I digested fragement of 
pBE3 including natural subtilisin E promoter was cleaved off and inserted into a commercial 
shuttle vector pHY300PLK to constructe the expression plasmid pHY300PLK-aprE. 
3.1.2 Development of screening systems 
Eight different substrates or methods were investigated for screening for chaotrope 
resistance (GdmCl or SDS) in microtiter plates (MTP). The comparison is summarized 
in Table 3.3. Two substrates, Skim-milk and Casein (F-C) (using Folin & Ciocalteu's 
Phenol Reagent to develop blue color) [114] are not suitable for chaotolerance 
screening due to cross-interactions. Standard casein assay, which doesn’t have 
interaction problem, is still not recommended for further study, because of its less 
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Figure 3.2 Expression of subtilisin E in B. subtilis WB600. A) SDS-PAGE analysis of 
expression of subtilisin E in B. subtilis WB600 harboring pHY-aprE or pBE3*. B) Detection of 
proteolytic activity of subtilisin E by visible halos on 1 % Skim milk agar plates.  
sensitivity, tricky handling and high cost of materials (quartz MTPs are required). The 
fluorescent substrate Casein-FITC [115] is not suitable because of its high background. 
Another azurine-cross-linked substrate, Casein-AZCL (Megazyme International 
Ireland, Wicklow, Ireland), which could be an alternative agar-plate assay and has no 
interaction with denaturants, is not suitable for MTP screening, since it’s difficult to 
keep a homogeneous solution in each well due to its insolubility in aqueous solutions. 
The assays using Suc-AAPF-pNA or Suc-AAPF-AMC, have a high sensitivity, low 
background and no cross-interaction with chaotropes, despite that they are specific 
for certain proteases. Azocasein gives a low sensitivity despite no cross-interaction 
with chaotropes.  
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Table 3.3 Comparison of different substrates or methods investigated for screening for 
tolerance towards chaotropes in microtiter plates 
 
Substrate Type Advantage Disadvantage 
Skim-milk Spectrophotometric Very cheap, 
unspecific 
Degraded by SDS or 
GdmCl 
Casein Spectrophotometric Cheap, classic, 
unspecific 
Less sensitive, tricky 
handling, quartz MTP 
required 
Casein (F-C) Colorimetric Classic, unspecific Interaction between F-C 
reagents and GdmCl 
Casein-AZCL Colorimetric Sensitive, unspecific Less homogeneous 
Azocasein Colorimetric  Unspecific Less sensitive 
Suc-AAPF-pNA Colorimetric Sensitive, standard 
for characterization 
Expensive, specific 
Suc-AAPF-AMC Fluorescent Very sensitive Specific 
Casein-FITC Fluorescent Sensitive, unspecific High background 
 
    A screening strategy was finally proposed after consideration of all the Pros and 
Cons. Figure 3.4 shows the screening procedure from mutant library generation, 
pre-screening in agar plates, and microtiter plate based screening systems to identify 
subtilisin E variants with improved resistance (Suc-AAPF-AMC detection system) and 
preserved activity towards complex substrates (Skim-milk activity detection system). 
 
Figure 3.4 Screening procedure employed in each round of directed evolution. The screening 
procedure comprises a pre-screening on Skim-milk agar plates (1 % Skim milk) for active 
variant identification followed by two 96-well microtiter plate screening systems. The latter 
quantify GdmCl or SDS resistance of subtilisin E variants and investigate whether resistance 
improved subtilisin E variants still digest efficiently complex protein substrates. 
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    The Skim milk agar plate assay was used for pre-screening and ruling out the 
inactive clones. Active clones were therefore selected and subjected to subsequent 
screening in 96-well MTPs in the absence and presence of GdmCl or SDS by using 
two substrates (see Figure 3.4). All screening conditions were optimized and discribed 
in details in Matericals and Methods (see section 2.2.7). Coefficient of variations (CV) 
in 96-well MTP based Suc-AAPF-AMC screening were determined for subtilisin E to 
be: 10.9 % (1 M GdmCl); 7.0 % (0.5 % SDS), and 6.5 % (no denaturant), and the 
coefficient of variations was determined to be 16.8 % for the Skim-milk detection 
system (see Figure 3.5), Coefficient of variations below 20 % in MTP has been 
commonly accepted for directed evolution experiments [116]. The resistance ratio 
(chaotrope: GdmCl or SDS) and activity ratio (substrate: Suc-AAPF-AMC or Skim-milk) 
were calculated as follows to identify improved subtilisin E variants: 
 
Resistance Ratio (chaotrope) = (A (+)chaotrope / A (-)chaotrope) Variant  / (A 
(+)chaotrope / A (-)chaotrope ) WT  (1) 
 
Activity Ratio (substrate) = A Variant / A WT  (2) 
In Ratio (1), the activity A in the presence of chaotropes (marked as “+”) on 
Suc-AAPF-AMC as substrate was divided by the one in the absence (marked as “-“) 
to “eliminate” expression mutants. Ratio (1) shows improvements compared to the 
wild type (WT). Ratio (2) measures the ability of subtilisin E variants to still convert 
substrates, especially complex protein, efficiently. The latter is an important 
prerequisite for application in diagnostic kits. Both ratios were taken into account for 
selecting beneficial subtilisin E mutants in three rounds of directed evolution. 
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Figure 3.5 Evaluation of coefficient of variations (CV) in 96 well-MTP based screening assays. 
A) Suc-AAPF-AMC assay in the absence of chaotropes. B) Suc-AAPF-AMC assay in 1 M 
GdmCl. C) Suc-AAPF-AMC assay in 0.5 % SDS. D) Skim milk assay in the absence of 
chotropes. 
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3.1.3 Construction of random mutagenesis libraries 
3.1.3.1 epPCR libraries 
Three iterative rounds of directed evolution were carried out in which first two epPCR 
mutant libraries were screened by sampling per library ~1300 clones. Various 
concentrations of MnCl2 coupled with unbalanced dNTP (dGTP>> dATP = dCTP = 
dTTP) were investigated for generating epPCR libraries (see Figure 3.6). Conditions 
mentioned above were selected after mutagenesis assistant program (MAP) analysis 
[24] to maximize charged substitutions. Charged substitutions were regarded as 
beneficial ones with the assumption that more charged residues on the surface 
improve interactions with cosolvents. A concentration of 0.10 mM MnCl2 coupled with 
unbalanced dNTP (0.4 mM dGTP, 0.2 mM dATP = dCTP = dTTP), which generated 
~50 % active mutants was selected finally for generation of both epPCR libraries (see 
Table 3.7).  
 
Figure 3.6 Gel electrophoresis analysis of epPCR products. A) PCR products of amplified 
vector and insert by PLICing methods 
[96]
. M, DNA marker; V, vector (pHY-aprE
-
); I, aprE (WT) 
insert. B) epPCR products of insertion by PLICing with addition of different concentrations of 
MnCl2 and unbalanced dNTP (0.4 mM G, 0.2 mM A=C=T). M, DNA marker; Lane 1, 0.1 mM 
MnCl2; Lane 2, 0.2 mM MnCl2; Lane 3, 0.3 mM MnCl2. 
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Table 3.7 Optimization of concentrations of MnCl2 for generation of epPCR libraries 
Conditions Active Ratio (%) 
Control
1
 ~100 
0.1 mM MnCl2, G>>
2
 50~60 
0.2 mM MnCl2, G>> 15~20 
0.3 mM MnCl2, G>> 5~10 
1: Control indicates the conditions without MnCl2 and/or unbalanced dNTP. 
 2: G>> indicates 0.4 mM G, 0.2 mM A=C=T as unbalanced dNTP condition. 
3.1.3.2 SeSaM library 
Eight improved variants after screening of two iterative rounds of epPCR libraries 
were selected and mixed as the template for generation of the next round of SeSaM 
[33] library. The protocol was derived from SeSaM Tv-Handbook (classic) Revision 
0.16 provided by SeSaM-Biotech GmbH. 
    Optimal phosphorothioate percentage was determined experimentally (see 
Figure 3.8): A_fwd library (dATPαS 22 %), G_fwd library (dGTPαS 18 %), A_rev 
library (dATPαS 32 %), G_rev library (dGTPαS 22 %). 
 
Figure 3.8 Fluorescent scanning of PCR products at different percentage of phosphorothioate 
nucleotides. A or G indicates library type; the number indicates the percentage (%) of 
phosphorothioate nucleotides.  
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    The rest of protocols were performed according to the Handbook. The final 
libraries were mixed and amplified by the PLICing method (see Figure 3.9). The PCR 
products were further digested, ligased and transformed into E. coli DH5α and then 
into the host strain B. subtilis WB600. The active was ~33 % of variants for this round 
of SeSaM Library, and ~1300 clones were screened. 
 
 
Figure 3.9 Gel electrophoresis analysis of PCR products for generation of SeSaM libraries. M, 
DNA marker. V, vector (pHY-aprE
-
); I, aprE (SeSaM libraries) insert.    
3.1.4 Screening of random mutagenesis libraries 
Microtiter plate screening in the presence and absence of 1 M GdmCl or 0.5 % SDS 
and a Skim-milk activity screening were performed in parallel. Variants with a ratio (2) 
>0.3 (Skim-milk assay) were further screened with Suc-AAPF-AMC assays for 
improved resistance and variants with a ratio (1) >1.2 (1st round epPCR), >1.4 (2nd 
round epPCR), >2.5 (SeSaM) were used for diversity generation in the next round of 
directed evolution. 
3.1.4.1 1st round of screening – epPCR1 
In the first round, an epPCR library was screened (see section 3.1.3). MTP assays by 
using Suc-AAPF-AMC as substrate in the presence and absence of 1 M GdmCl or 
0.5 % SDS, as well as Skim-milk assay were performed in parallel.  
    In all, 15 MTPs, including all 1350 active mutants were screened. Mutants, which 
showed no less than 30 % of residual activity towards Skim-milk and above 20 % of 
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residual activity enrichment either in 1 M GdmCl or 0.5 % SDS, were selected for 
rescreening to confirm their improvement.  
    Finally, 90 mutants of interest were selected and re-screened. 12 mutants of 
interest were thus selected and characterized (see Table 3.10). Their plasmids were 
isolated and mixed as the template for the next round of directed evolution. 
 
Table 3.10 Overview of properties of selected variants from 1
st
 round of epPCR library. The 
chaotolerance ratios (1 M GdmCl or 0.5 % SDS) or activity ratios (AAPF or Skim-milk) are 
calculated according to equations in section 3.1.2. Expression level of selected variants is also 
compared to the wild type as indicated.  
Variants 1 2 3 4 5 6 7 8 9 10 11 12 
1 M GdmCl 1.2  1.4 1.5  1.4  1.2  1.5  1.1  1.4  0.9  1.2  1.5  0.5  
0.5 % SDS 1.1  1.2  1.2  1.2  1.0  1.2  1.2  1.2  0.9  1.1  1.2  1.4  
AAPF 2.0  2.0  1.5  2.0  2.1  1.6  1.0  1.0  2.2  2.1  1.5  0.6  
Skim-milk 2.2  0.7  1.0  0.9  2.1  1.0  0.7  1.0  1.3  2.0  1.1  0.8 
Expression ↑ = ↓ ↑ = = = ↓ ↑ ↑ = = 
3.1.4.2 2nd round of screening – epPCR2 
The screening of second round of epPCR library (1260 clones) was carried out in the 
same way as the first round. Mutants which showed more than 50 % of residual 
activity towards Skim-milk and above 40 % of residual activity enhancement either in 
1 M GdmCl or 0.5 % SDS were selected for rescreening.  
 
Finally, 52 mutants of interest were selected and rescreened. 8 mutants of interest 
were thus selected and characterized (see Table 3.11). Their plasmids were isolated 
and mixed as the template for the next round of directed evolution. 
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Table 3.11 Overview of properties of selected mutants from 2
nd
 round of epPCR library. The 
chaotolerance ratios (1 M GdmCl or 0.5 % SDS) or activity ratios (AAPF or Skim-milk) are 
calculated according to equations in section 3.1.2. Expression level of selected variants is also 
compared to the wild type as indicated. 
Variants 1 2 3 4 5 6 7 8 
1 M GdmCl 2.1  0.5  2.3  2.0  2.6  2.2  1.9  2.0  
0.5 % SDS 1.4  1.5  1.4  1.4  1.4  1.4  1.4  1.4  
AAPF 2.2  0.7  1.7  2.8  3.1  2.1  1.9  1.7  
Skim-milk 0.9  0.7  0.7  1.0  0.6  0.9  0.8  0.6  
Expression ↑ = ↓ ↑ ↑ ↑ = ↑ 
3.1.4.3 3rd round of screening- SeSaM1 
Screening of the SeSaM library was carried out in the same way as for epPCR 
libraries. Mutants which showed more than 30 % of residual activity towards 
Skim-milk and above 2.5 of resistance ratio in 1 M GdmCl or above 2.2 in 0.5 % SDS 
were selected for rescreening. Finally, 85 mutants of interest were selected and 
re-screened. 10 mutants of interest were selected and confirmed (see Table 3.12).  
Table 3.12 Overview of properties of selected mutants from 1
st
 round of SeSaM library. The 
chaotolerance ratios (1 M GdmCl or 0.5 % SDS) or activity ratios (AAPF or Skim-milk) are 
calculated according to equations in section 3.1.2. Expression level of selected variants is also 
compared to the wild type as indicated. 
Variants 1 2 3 4 5 6* 7 8 9 10 
1 M GdmCl 3.6  4.0  4.2  3.4  4.8  4.2  3.4  3.9  3.9  1.5  
0.5 % SDS 2.5  2.9  2.9  4.2  4.9  2.8  2.4  1.4  2.6  2.7  
AAPF 5.3  5.0  4.7  1.9  1.8  4.7  5.1  5.0  5.0  0.9  
Skim-milk 0.7  0.5  0.4  0.7  0.3  0.6  2.0  0.6  0.6  0.5 
Expression ↓ ↓ = ↓ ↓↓ - = ↓ ↓ ↓↓ 
* No.6 mutant completely lost its activity and resistance during the isolation probably due to plasmid loss. 
3.1.5 Comparison of selected variants 
After three rounds of directed evolution, a few variants with highly improved tolerance 
towards GdmCl or SDS were identified. Substitutions of selected variants from all 
three rounds of directed evolution were summarized in Table 3.13. Variants 
designated as ep1-8, ep2-3 and SeSaM1-5, were considered as the “best”
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Table 3.13 Overview of substitutions and properties of all selected variants from three rounds of directed evolution. 
1. The order of number for amino acid substitution starts from mature domain of subtilisin E.  
2. The concentration of GdmCl for screening is 1 M, while the concentration of SDS is 0.5 %.  
* The underlined amino acid substitutions indicate the ones that have been reported in subtilisin E or its homologs.  
** The variants highlighted in red indicate the “best” variant from corresponding round of directed evolution. 
 
 
 
Variants A1E
1
* S62I D97A Q103P V149A A153V G166S N181D N184H I205V N218S T224A A232V T240S GdmCl
2
 SDS
2
 AAPF Skim-milk Expression 
ep1-4            +   1.4 1.2 2.0 0.9 ↑ 
ep1-8**     +          1.4 1.2 1.0 1.0 ↓ 
ep1-12    +           0.5 1.4 0.6 0.8 = 
ep2-2    +           0.5 1.5 0.7 0.7 = 
ep2-3      + +   +     2.3 1.4 1.7 0.7 ↓ 
ep2-5           + +   2.6 1.4 3.1 0.6 ↑ 
SeSaM1-1      + +    + +   3.6 2.5 5.3 0.7 ↓ 
SeSaM1-2      + +   + + +   4.0 2.9 5.0 0.5 ↓ 
SeSaM1-3 +     + +   + + + +  4.2 2.9 4.7 0.4 = 
SeSaM1-4   +   + + +  +     3.4 4.2 1.9 0.7 ↓ 
SeSaM1-5  +    + +   +     4.8 4.9 1.8 0.3 ↓ 
SeSaM1-7      + +     +  + 3.4 2.4 5.1 2.0 = 
SeSaM1-8      + +  +  + +   3.9 1.4 5.0 0.6 ↓ 
SeSaM1-9      + +    + +   3.9 2.6 5.0 0.6 ↓ 
 
Chapter 3 - Results 
55 
 
representative mutants in their corresponding round of directed evolution, and were 
subjected to activity assays in varied concentrations of GdmCl (1-5 M) or SDS 
(0.5-2.0%) for comparison (see Figure 3.14). Further comparison and validation are 
described in next section. 
 
Figure 3.14 Comparison of GdmCl- and SDS-resistance of selected variants in cell-free 
supernatants from three rounds of directed evolution. A) Comparison of activities in the 
presence of different concentrations of GdmCl. B) Comparison of activities in the presence of 
different concentrations of SDS. The relative activities of cell-free supernatants were 
calculated by using Suc-AAPF-AMC as substrate in Tris-HCl buffer (0.1 M, pH 8.5) in the 
absence and presence of GdmCl or SDS, considering activity in the absence of GdmCl or SDS 
as 100 %. 
3.2 Site saturation mutagenesis and recombination of 
beneficial substitutions 
All 14 substitutions identified (see section 3.1.5) among selected variants in terms of 
their improved GdmCl- or SDS-resistance were investigated by site saturation 
mutagenesis (SSM). The study was conducted in two parts: one focused on 4 
positions identified in the “best” mutant SeSaM1-5, designated as M4, and the other 
focused on the other 10 positions. The recombinatorial study of beneficial 
substitutions was followed after screening and confirmation, which details in Figure 
3.15. 
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Figure 3.15 Overview of site saturation mutagenesis (SSM) and recombination of 
substitutions in subtilisin E identified in directed evolution. Study I focused on the substitutions 
in the “best” variant SeSaM1-5 (M4). Study II focused on the other substitutions. Single 
substitution in the box indicates the “best” single one at its positions in terms of GdmCl- or 
SDS-resistance. Recombinant variants M2, M5 and M6 were constructed as indicated. 
3.2.1 Construction and screening of SSM libraries 
The construction of SSM libraries at position 62, 166, 153, 205 (Study I) and at 
position 1, 97, 103, 149, 181, 184, 218, 224, 232, 240 (Study II) were carried out using 
the QuikChange method [99]. The SSM libraries were then transformed into B. subtilis 
WB600 for further screening. 
    180 clones for each SSM library were subjected to screening in duplicate under 
the same conditions of the directed evolution experimetns, and the results were 
detailed in Figure 3.16.  
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Figure 3.16 Overview of screening results of site saturation mutagenesis (SSM) libraries at 
positions 62, 153, 166 and 205 (Study I) and position 1, 97, 103, 149, 181, 184, 218, 224, 232 
and 240 (Study II) identified from selected variants from directed evolution. 180 clones for 
each SSM library were screened in duplicate and their chaotolerance ratios (1 M GdmCl or 
0.5 % SDS) and activity ratios (AAPF or Skim milk) were calculated and shown as indicated. 
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    Further rescreening and confirmation proved that substitutions at position 62, 166 
(Study I), 97, 103, 218 and 224 (Study II) have evident effects on GdmCl- and/or SDS- 
resistance. The improved variants were isolated and their substitutions were 
confirmed by sequencing (see Table 3.17).   
 
Table 3.17 Overview of all beneficial substitutions for GdmCl- and/or SDS-resistance. The 
number of sequenced clones with beneficial substitutions is listed. The chaotolerance ratios (1 
M GdmCl or 0.5 % SDS) or activity ratios (AAPF or Skim-milk) are calculated according to 
equations in section 3.1.2. Expression level of selected variants is also compared to the wild 
type as indicated. 
Substitutions 
Number 
(All) 
Properties (Ratios) 
GdmCl SDS AAPF Skim-milk Expression 
S62T 3(10) 1.3  1.4  0.4  1.3  = 
S62I
1,2
 2(10) 2.0  1.7  2.5  0.4  = 
S62F 2(10) 1.6  1.5  2.7  0.5  = 
S62L 1(10) 1.5  1.7  2.8  0.6  = 
S62C 1(10) 1.5  0.6  1.5  0.2  = 
S62K 1(10) 1.1  0.1  0.4  0.5  = 
G166A 3(13) 2.2 1.5 3.5 0.9 = 
G166F 3(13) 2.1  1.4  0.9 0.6 = 
G166S 2(13) 1.8  1.1  1.7  1.0  = 
G166C 2(13) 1.9  1.5  2.0  0.7  = 
G166M 2(13) 2.5  2.0  3.3  0.9  = 
G166Y 1(13) 1.6  1.2  0.7  0.8  = 
    D97A 1(1) 1.1 1.4 2.5 0.8 = 
Q103D 1(6) 2.2 0.9 0.2 0.6 ↓ 
Q103P 3(6) 0.6 1.5 0.6 1.0 ↓ 
Q103E 2(6) 1.5 1.0 0.4 0.9 ↓ 
N218S 4(4) 1.4  1.2  2.2  0.6  = 
T224S 7(12) 1.6  1.2  3.4  0.9  = 
T224C 3(12) 1.4  1.3  3.0  1.4  = 
T224A 1(12) 1.4  1.1  3.7  1.3  = 
T224G 1(12) 1.4  1.0  2.1  0.5  = 
1. Underlined substitutions are also found in variants from directed evolution.  
2. The variants highlighted in red indicate the best single variant from each SSM library.  
 
    The substitutions responsible for GdmCl- and/or SDS- tolerance have no specific 
patterns. However, all these positions are located either close to active site residues, 
such as S62 adjacent to H64 and position N218, T224 adjacent to S221, or close to 
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substrate binding pockets, such as position G166 in specific binding pocket P1 and 
position D97 or Q103 close or in unspecific substrate binding site P4 (see Figure 1.1 
and Figure 3.18). Roughly a glimpse of substitutions at position 62 and 166, as well as 
224, which have dominant impacts on GdmCl- and SDS-resistance, reveals that most 
are hydrophobic residues. Notabily, only single substitution is found responsible for 
tolerance at position 97 (D97A) and 218 (N218S), while substitution D97A only 
accounts for SDS tolerance. Interestingly, two substitutions, Q103D and Q103P were 
responsible specifically for GdmCl tolerance or SDS tolerance at position 103 
respectively, but with dramatically reduced activity towards Suc-AAPF-AMC as 
substrate (see Table 3.17). More analysis for proposed mechanism of improved 
tolerance caused by these substitutions is detailed in the Discussion chapter. 
 
Figure 3.18 Schematic representation of subtilisin E wild type with identified amino acid 
substitutions. Six positions of amino acid substitutions (S62, G166, D97, Q103, N218 and 
T224 in yellow in sphere format) identified by site saturation mutagenesis (SSM) are labeled. 
Catalytic triad (D32, H64 and S221) is shown in red and labeled. The model was generated 
based on crystal structure complex of subtilisin E (PDB code: 1SCJ) by removing the 
propeptide and mutation of C221 to its catalytic residue S221. 
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3.2.2 Recombination of beneficial mutations 
As seen in Figure 3.15, several recombinant variants were constructed based on the 
results of site saturation mutagenesis experiments: M2 (S62I/G166M) was generated 
by combination of two “best” single substitutions in Study I (S62I and G166M); M5 
(S62I/A153V/G166S/T224A/T240S) was generated in Study II by additional 
substitution of S62I by site directed mutagenesis in variant SeSaM1-7, the only 
variant from directed evolution with enhanced activity towards complex substrate (see 
Table 3.13), to increase its tolerance but intentionally retain the activity towards 
complex substrate; M6 (S62I/A153V/G166S/I205V/N218S/T224A) was constructed in 
Study II by introduction of additional substitutions of N218S and T224A by site 
directed mutagenesis in variant SeSaM1-5 (M4) to further enhance its GdmCl- and/or 
SDS-resistance. Besides, some neutral single substitutions, revealed by site 
saturation mutagenesis, were also constructed by site directed mutagenesis for 
comparison, such as A153V, I205V (in SeSaM1-5) and T240S (in SeSaM1-7). 
3.2.2.1 Study I: 1st round of SSM and recombination 
The cell-free supernatants of selected variants in Study I were subjected to extensive 
activity assays in the presence of different concentrations of GdmCl or SDS. The 
results were showed in Figure 3.19 and more details were shown in Table 3.20. The 
results showed that two positions (62 and 166) contributed mainly to the improved 
resistance towards GdmCl and SDS. A153V and I205V, which were maintained in 
variant SeSaM1-5 (M4) had no superior resistance than the wild type (see Figure 
3.19). As previously shown in section 3.2.1, SSM of position 62 yielded again the 
substitution S62I as most beneficial one. SSM of position 166 yielded as the “best” 
variant a different substitution (G166M instead of G166S) which is apparently more 
resistant. Finally a double mutant (M2: S62I and G166M) was generated by site 
directed mutagenesis. Comparison of the performance of M2 and SeSaM1-5 (M4) in 
Figure 3.19 shows a comparable activity on Skim-milk. In respect to GdmCl- and 
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SDS-resistance the SeSaM1-5 (M4) variant performs slightly better than M2 under 
screening conditions. The latter indicates a cooperative effect within the substitutions 
of SeSaM1-5 (M4) in the presence of Suc-AAPF-AMC. 
 
Figure 3.19 Activity and resistance ratios of subtilisin E variants (Study I) in the presence or 
absence of chaotropes. All ratios of subtilisin E variants in cell-free supernatants were 
calculated by using Suc-AAPF-AMC as substrate in Tris-HCl buffer (0.1 M, pH 8.5) in the 
absence and presence of 1 M GdmCl or 0.5 % SDS and normalized in U/mg using the Agilent 
Protein 230 Kit. Activity and resistance ratios were calculated from independent 
measurements in triplicate with standard deviation indicated. Activity ratios for both 
Suc-AAPF-AMC and Skim-milk as substrates without chaotropes were calculated according to 
equation for Ratio (2) and displayed as □: Suc-AAPF-AMC, ■: Skim-milk. Resistance ratios in 
the presence of 1 M GdmCl or 0.5 % SDS using Suc-AAPF-AMC as substrate were calculated 
according to equation for Ratio (1) and displayed as ■: 1 M GdmCl, ■: 0.5 % SDS. 
3.2.2.2 Study II: 2nd round of SSM and recombination 
The cell-free supernatants of selected variants in Study II were subjected to extensive 
activity assays in the presence of different concentrations of GdmCl or SDS. The 
results were showed in Figure 3.21 and more details were listed in Table 3.22. N218S 
and T224A have moderate effects on both GdmCl and SDS tolerance, and that is also 
why they were selected to introduce into M4 to generate M6 for further improvement 
at the first place. However, D97A and Q103P has only moderate effects on SDS 
tolerance, while Q103D has apparent effects on GdmCl tolerance, but loses 70 % 
activity on Suc-AAPF-AMC as substrate (see Figure 3.22). Thus they were not 
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Table 3.20 Specific activity of subtilisin E variants (Study I) and their ratios in the presence or absence of chaotropes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variants 
No GdmCl SDS Skim- 
chaotropes 1 M 2 M 3 M 4 M 5 M 0.50% 1.00% 1.50% 2.00% milk 
Wild type 
591.56 
[1]
 113.53  N.D. N.D. N.D. N.D. 189.68  95.47  42.40  23.07    
1.00 
[2]
 1.00 
[3]
 - - - - 1.00 
[3]
 1.00  1.00  1.00  1.00 
[2]
 
SeSaM1-5  
1954.10  1697.56  1129.21  549.10  168.69  N.D. 2482.60  2036.75  1751.45  1541.32    
3.30  4.53  - - - - 3.96  6.46  12.51  20.22  0.56  
M2  
2354.70  1596.55  1071.92  597.74  274.16  63.67  2594.62  1988.38  1670.03  1428.65    
3.98  3.53  - - - - 3.44  5.23  9.90  15.56  0.44  
S62I 
1800.86  646.64  156.96  N.D. N.D. N.D. 921.48  511.33  359.18  278.29    
3.04  1.87  - - - - 1.60  1.76  2.78  3.96  0.52  
A153V 
1116.59  219.93  N.D. N.D. N.D. N.D. 441.39  235.97  137.08  58.04    
1.89  1.03  - - - - 1.23  1.31  1.71  1.33  1.47  
G166S 
1403.92  506.02  65.27  N.D. N.D. N.D. 654.68  352.37  222.83  140.52    
2.37  1.88  - - - - 1.45  1.56  2.21  2.57  1.12  
G166M 
2211.35  1010.93  275.20  34.59  N.D. N.D. 1215.83  784.85  584.99  418.19    
3.74  2.38  - - - - 1.71  2.20  3.69  4.85  0.96  
I205V 
890.85  195.98  N.D. N.D. N.D. N.D. 325.30  160.70  113.91  61.68    
1.51  1.15  - - - - 1.14  1.12  1.78  1.78  0.68  
[1] All specific activities of subtilisin E variants in cell-free supernatants were calculated by using Suc-AAPF-AMC as substrate in Tris-HCl 
buffer (0.1 M, pH 8.5) in the absence and presence of given concentrations of GdmCl or SDS and normalized in U/mg using the Agilent 
Protein 230 Kit. Activity and resistance measurements were carried out in triplicate with <10 % standard deviation. N.D. indicates that no 
activity could be detected. [2] Activity ratios towards both Suc-AAPF-AMC and Skim-milk as substrates were calculated according to equation 
for Ratio (2), and highlighted in bold. [3] Resistance ratios towards given concentrations of GdmCl or SDS were calculated according to 
equation for Ratio (1) and highlighted in bold. 
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Figure 3.21 Activity and resistance ratios of subtilisin E variants (Study II) in the presence or 
absence of chaotropes. All ratios of subtilisin E variants in cell-free supernatants were 
calculated by using Suc-AAPF-AMC as substrate in Tris-HCl buffer (0.1 M, pH 8.5) in the 
absence and presence of 1 M GdmCl or 0.5 % SDS and normalized in U/mg using Experion 
microfluidic system. Activity and resistance ratios were calculated from independent 
measurements in triplicate with standard deviation indicated. Activity ratios for both 
Suc-AAPF-AMC and Skim-milk as substrates without chaotropes were calculated according to 
equation for Ratio (2) and displayed as □: Suc-AAPF-AMC, ■: Skim-milk. Resistance ratios in 
the presence of 1 M GdmCl or 0.5 % SDS using Suc-AAPF-AMC as substrate were calculated 
according to equation for Ratio (1) and displayed as ■: 1 M GdmCl, ■: 0.5 % SDS. 
regarded as substitutions for combinations. M6, was constructed by introduction of 
N218S and T224A into SeSaM1-5 (M4), and showed the highest GdmCl- and 
SDS-resistance (1 M GdmCl: 5.7 fold; 0.5 % SDS: 4.2 fold) compared to SeSaM 1-5 
(M4, 1 M GdmCl: 4.5 fold; 0.5 % SDS: 4.0 fold) or M2 (1 M GdmCl: 3.5 fold; 0.5 % 
SDS: 3.4 fold). 
    SeSaM1-7, as mentioned previously, is the only variant from directed evolution 
which has improved activity towards complex substrate (1.6 fold) and retained 
moderate GdmCl- and SDS-resistance (1 M GdmCl: 3.3 fold; 0.5 %: 2.1 fold). 
Additional substitution S62I was introduced into this variant to construct M5 (see 
Figure 3.15) to attempt to retain its activity towards complex substrate but increase 
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Table 3.22 Specific activity of subtilisin E variants (Study II) and their ratios in the presence or absence of chaotropes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variants 
No GdmCl SDS Skim- 
chaotropes 1 M 2 M 3 M 4 M 5 M 0.50% 1.00% 1.50% 2.00% milk 
Wild type 
570.39 
[1]
 119.04  N.D. N.D. N.D. N.D. 191.52  95.16  43.06  25.59    
1.00 
[2]
 1.00 
[3]
 - - - - 1.00 
[3]
 1.00  1.00  1.00  1.00 
[2]
 
SeSaM1-7 
1778.48  1234.92  513.20  106.46  1.48  N.D. 1265.60  933.53  625.51  453.46    
3.12  3.33  - - - - 2.12  3.15  4.66  5.68  1.56  
M5 
2237.64  2184.60  1742.60  1088.64  391.70  68.48  3066.16  2823.52  2540.43  2396.05    
3.92  4.68  - - - - 4.08  7.56  15.04  23.85  1.08  
M6 
3335.20  3968.31  3621.43  2967.85  1812.91  764.60  4650.90  4654.79  4401.85  4259.18    
5.85  5.70  - - - - 4.15  8.37  17.48  28.44  0.41  
N218S 
1047.94  322.98  39.22  N.D. N.D. N.D. 478.78  277.85  162.92  115.05    
1.84  1.48  - - - - 1.36  1.59  2.06  2.45  0.60  
T224A 
1625.21  496.13  95.14  N.D. N.D. N.D. 738.70  411.68  262.48  182.41    
2.85  1.46  - - - - 1.35  1.52  2.14  2.50  1.13  
T240S 
316.27  61.08  N.D. N.D. N.D. N.D. 117.16  56.12  31.12  15.67    
0.55  0.93  - - - - 1.10  1.06  1.30  1.10  0.57  
Q103P 
446.43  42.78  N.D. N.D. N.D. N.D. 229.69  86.04  34.93  7.38    
0.78  0.46  - - - - 1.53  1.16  1.04  0.37  1.02  
Q103D 
161.76  56.02  N.D. N.D. N.D. N.D. 35.77  N.D. N.D. N.D.   
0.28  1.66  - - - - 0.66  - - - 0.92  
D97A 
1554.12  341.89  8.27  N.D. N.D. N.D. 703.88  300.92  174.10  73.68    
2.72  1.05  - - - - 1.35  1.16  1.48  1.06  0.97  
[1] All specific activities of subtilisin E variants in cell-free supernatants were calculated by using Suc-AAPF-AMC as substrate in Tris-HCl buffer (0.1 M, 
pH 8.5) in the absence and presence of given concentrations of GdmCl or SDS and normalized in U/mg using the Experion microfluidic system. Activity 
and resistance measurements were carried out in triplicate with <10 % standard deviation. N.D. indicates that no activity could be detected. [2] Activity 
ratios towards both Suc-AAPF-AMC and Skim-milk as substrates were calculated according to equation for Ratio (2), and highlighted in bold. [3] 
Resistance ratios towards given concentrations of GdmCl or SDS were calculated according to equation for Ratio (1) and highlighted in bold. 
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its GdmCl- and SDS-resistance. The results in Figure 3.21 showed that the activity of 
M5 towards Skim-milk was equal to wild type activity (1.1 fold) but the GdmCl- and 
SDS-resistance was improved (1 M GdmCl: 4.7 fold; 0.5 % SDS: 4.0 fold) compared 
to SeSaM1-7, and was slightly better than SeSaM 1-5 (M4, 1 M GdmCl: 4.5 fold; 0.5 % 
SDS: 4.0 fold). The single substitution T240S, which was maintained in variant 
SeSaM1-7 had no superior resistance than wild type (see Figure 3.21). Its effect on 
SeSaM1-7 regarding its enhanced activity towards complex substrate is unknown. 
However, its position is at the back of the active site, and it could be assumed that this 
substitution might have effects on flexibility of active sites, that indicated by structure 
analysis of protease K, a active protease with very broad substrate specificity [117].   
3.2.2.3 Recombination with SeSaM-based shuffling 
Though sequencial addition of single beneficial substitution into wild type (M2 in Study 
I) or other variants (M5 or M6 in Study II) generated more chaotolerant variants (see 
section 3.2.2.1 and 3.2.2.2), this approach rules out single neutral or even deleterious 
substitution which might become beneficial with collaborative effects in muteins. A 
new method “SeSaM-based shuffling” is designed and developed for random 
combination of all mutations of interest to overcome such drawback. 
    Fragmentation of both wild type (WT) and synthetic gene with mutations (M14, 
see Appendix I) was performed according to SeSaM Tv-Handbook (classic) Revision 
0.21 provided by SeSaM-Biotech GmbH. Optimal phosphorothioate percentage was 
determined experimentally for both WT and M14: G_fwd library (dGTPαS 40 %), 
G_rev library (dGTPαS 40 %). 
    Iodine digested fragments were then shuffled by PCR at different cycles to 
generate full length gene with different mutation recombinations. Different PCR cycles 
were thus investigated as well as gene template ratio WT:M14. Figure 3.23 showed 
the sequence coverage of 10 sequenced clones randomly picked from each 
SeSaM-based shuffling library. The statistical analysis indicates that the more M14 
template amount and more shuffling PCR cycles are, the more randomly shuffled 
 
Chapter 3 - Results 
66 
 
genes can be generated (more S2 sequences). However, the coverage of template 
sequences (WT and M14) is still not ruled out.  
 
Figure 3.23. Sequence coverage of SeSaM-based shuffled genes with different template 
ratios and shuffling PCR cycles. WT, wild type sequence. M14, synthetic gene sequence (14 
amino acid substitutions in yellow). S1, randomly shuffled gene sequence type 1 (without 
gaps). S2, randomly shuffled gene sequence type 2 (with gaps). Wild type and synthetic gene 
template ratios and shuffling PCR cycles are indicated for instance 1:1_15 with 1:1 for WT to 
M14 ratio and 15 for shuffling PCR cycles. 
    Screening of all five SeSaM-based shuffling libraries (~300 clones for each) 
resulted in dramatic loss of activity towards complex substrate Skim-milk (see Table 
3.24). Additionally the chaotolerance ratios of selected “best” variant 1:2_45_3F11 
with 10 substitutions were only comparable to SeSaM1-5 (M4) (see Table 3.13). It 
might be due to screening of the limited number of clones from each library (~300 
clones for each), since combination of all 14 mutations requires 214 (16,384) as the 
library size in theory. It is also observed that some substitutions were difficult to 
separate because they were very close to each other, such as position 218, 224, 232 
and 240. Besides, the expression of all these improved variants decreased probably 
due to the high mutation load (see Table 3.24). 
    All above results show SeSaM-based shuffling is a feasible new method for 
random recombination of mutations of interest. However, more investigations are still 
required for further improvement. 
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Table 3.24 Overview of substitutions and properties of selected variants from SeSaM-based shuffling libraries. 
 
  1. The order of number for amino acid substitution starts from mature domain of subtilisin E. 
  2. The concentration of GdmCl for screening is 1 M, while the concentration of SDS is 0.5 %. 
 
 
 
 
 
 
 
 
 
Variants A1E
1
 S62I D97A Q103P V149A A153V G166S N181D N184H I205V N218S T224A A232V T240S GdmCl
2
 SDS
2
 AAPF Skim-milk Expression 
1:2_30_1C8 + +      + + + + + + + 3.3 3.2 7.8 0.1 ↓ 
1:2_30_3C4  +     + + + + + + + + 4.7 5.2 3.5 0.1 ↓ 
1:2_30_3G10 + + +     +   + + + + 3.5 4.5 3.3 0.0 ↓ 
1:2_45_1F5 + +        + + + + + 3.4 3.1 8.0 0.1 ↓ 
1:2_45_1H4 + +        + + + + + 3.3 3.1 7.9 0.1 ↓ 
1:2_45_3F11 + +     + + + + + + + + 4.8 5.2 3.8 0.0 ↓ 
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3.2.3 Purification of subtilisin E and its variants 
3.2.3.1 Study I: 1st round of SSM and recombination 
The purification of wild type, S62I, G166M, SeSaM1-5 (M4) and M2 was performed by 
using a two-step ion exchange chromatography procedure (see Method 1 in 2.2.8). 
SDS-PAGE analysis revealed that this protocol was successful in protease 
purification (see Figure 3.25).     
    The purity of variant enyzmes was confirmed by Agilent Protein 230 Kit, and the 
contents of all purified variants were above 85 % (see Figure 3.26). 
 
 
Figure 3.25 SDS-PAGE analysis of purification of subtilisin E and its variants (Method 1). M: 
Protein marker; raw, cell-free supernatant after filtration; ultra, ultra-filtrated enzyme solution; 
SuperQ, collected fractions after purification through anion exchange column SuperQ650; SP, 
collected fraction after purification through cation exchange column SP650c.  
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Figure 3.26 Agilent analysis of purified subtislin E and its variants (Study I). The contents of 
purified subtilisin E are all >85 %. 
3.2.3.2 Study II: 2nd round of SSM and recombination 
The purification of wild type, SeSaM1-4 (M4), N218S, T224A, M5 and M6 was 
performed by using a two-step ion exchange chromotrography procedure (see 
Method 2 in 2.2.8). SDS-PAGE analysis revealed that this protocol was also 
successful (see Figure 3.27). Besides, the yield was also improved (data not shown). 
    The purity of these purified enzymes is confirmed by an Experion microfluidic 
system, and the contents of the purified wild type, M4, N218S and T224A were all 
around 90 %, while the M5 and M6 content was around 80 % (see Figure 3.28). 
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Figure 3.27 SDS-PAGE analysis of purification of subtilisin E and its variants (Method 2). M: 
Protein marker; raw, cell-free supernant after filtration; ultra, ultra-filtrated enzyme solution; 
CM: collected fractions after purification through cation exchange column CM650; SuperQ, 
collected fractions after purification through anion exchange column SuperQ650, 1&2 indicate 
the order of purification steps with SuperQ650 for M5 and M6. 
 
 
Figure 3.28 Experion analysis of purified subtilisin E and its variants (Study II). The contents of 
purified Subtilisin E are either around 90 % (WT, M4, N218S and T224A) or around 80 % (M5 
and M6). 
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3.2.4 Characterization of subtilisin E and its variants 
3.2.4.1 Determination of kinetic constants 
Table 3.29 lists the kinetic data of the purified wild type subtilisin E and obtained 
subtilisin E variants (S62I, G166M, M2 (S62I/G166M), SeSaM1-5 (M4)) purified by 
Method 1 in respect to kcat, Km and kcat/Km. 
    In the absence of GdmCl or SDS the kcat value was improved from 50 s
-1 (wild 
type) to 141 s-1 (G166M), 123 s-1 (M2), and 102 s-1 (S62I). SeSaM1-5 has however a 
lower kcat value (42 s
-1). In the presence of 2 M GdmCl the specific activity from 
SeSaM1-5 is reduced to 34 s-1 and the wild type activity to 15 s-1. M2’s and G166M’s 
specific activity are in absolute values higher than the one of SeSaM1-5 (62 s-1 & 70 
s-1; see Table 3.29). In SDS a similar trend can be observed with the following 
“resistance order” (35 s-1 wild type < 45 s-1 SeSaM1-5 < 65 s-1 S62I < 81 s-1 M2 < 104 
s-1 G166M).  
    Interestingly, the Km value for SeSaM1-5 (M4) was significantly reduced 
compared to the subtilisin E wild type in GdmCl (up to 8-fold (No chaotrope), 28-fold 
(1 M), and 46-fold (2 M)) and SDS (7 fold (0.5 %); see Table 3.29). 
    The catalytic efficiency improves in the absence of GdmCl or SDS in the following 
order (see Table 3.29): G166M (3 fold) < S62I (4 fold) ≈ M2 (4 fold) < SeSaM1-5 (6 
fold). In presence of 2 M GdmCl: G166M (22 fold) < S62I (45 fold) < SeSaM1-5 (100 
fold) < M2 (118 fold). In presence of 0.5 % SDS: G166M (7 fold) < SeSaM1-5 (9 fold) 
≈ S62I (9 fold) < M2 (13 fold). 
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Table 3.29 Kinetic constants of substilisin E wild type and variants for the hydrolysis of 
Suc-AAPF-pNA 
 
3.2.4.2 Activity in the presence of chaotropes 
Different residual activities of purified subtilisin E variants (Study II) in the presence of 
various concentrations of GdmCl or SDS towards Suc-AAPF-pNA as substrate were 
measured. Thus, the inactivation curve was drawn to evaluate their activity in these 
chaotropic agents. IC50 values, the concentration at which 50 % of activity of these 
variants retained under measuring conditions (see Material and Methods 2.2.10), 
were determined for comparison of their capability of tolerance towards GdmCl or 
SDS (see Figure 3.30 and Table 3.31). 
Variants Chaotropes 
Km  kcat             kcat/Km    
(mM) (s
-1
) (mM
-1
·s
-1
) 
Wild type No chaotrope 1.03±0.17 50.3±3.0 48,8±0.2 
  1 M GdmCl 1.93±0.11 22.6±0.4 11.8±0.1 
  2 M GdmCl 7.31±0.58 15.2±0.6 2.1±0.1 
  0.5 % SDS 2.45±0.18 35.0±0.9 14.3±0.1 
SeSaM1-5 No chaotrope 0.13±0.01 42.1±0.6 315.9±0.1 
(M4) 1 M GdmCl 0.07±0.01 38.4±1.0 539.6±0.2 
  2 M GdmCl 0.16±0.01 33.7±0.7 211.0±0.1 
  0.5 % SDS 0.35±0.03 44.5±0.9 125.8±0.1 
S62I No chaotrope 0.48±0.05 101.8±4.3 211.0±0.1 
  1 M GdmCl 0.15±0.01 31.5±0.5 208.9±0.1 
  2 M GdmCl 0.21±0.01 19.5±0.2 93.7±0.0 
  0.5 % SDS 0.50±0.05 64.5±1.8 130.2±0.1 
G166M No chaotrope 0.83±0.04 140.9±2.9 169.7±0.1 
  1 M GdmCl 0.67±0.02 96.2±0.8 144.0±0.0 
  2 M GdmCl 1.54±0.07 69.8±1.3 45.4±0.1 
  0.5 % SDS 0.97±0.04 103.5±1.4 106.8±0.1 
M2 No chaotrope 0.57±0.06 123.0±4.8 216.9±0.1 
  1 M GdmCl 0.19±0.01 81.7±1.3 428.7±0.1 
  2 M GdmCl 0.25±0.02 61.5±1.4 246.9±0.1 
  0.5 % SDS 0.45±0.05 80.5±2.4 179.3±0.1 
Values are the means of three separate determinations and are shown ± the standard deviation 
of these means.  
 
Chapter 3 - Results 
73 
 
 
Figure 3.30 Inactivation curve of purified subtilisin E variants (50 nM) in the presence of 
chaotropes. A) Subtilisin E variants in the presence of GdmCl at different concentrations (0 – 
6.0 M); B) Subtilisin E variants in the presence of SDS at different concentrations (0 – 4.0 %).  
    Both single mutants from Study II, N218S and T224A have slightly improved 
tolerance towards GdmCl [IC50 (N218S) 0.96 M; IC50 (T224A) 1.26 M] and SDS [IC50 
(N218S) 0.29 %; IC50 (T224) 0.43 %] compared to WT [IC50 (GdmCl) 0.76 M; IC50 
(SDS) 0.29 %]. But N218S seems more resistant towards GdmCl at higher  
Table 3.31 Determination of IC50 of purified subtilisin E in the presence of GdmCl or SDS. 
Variants WT  M4  M5  M6  N218S  T224A  
IC50 
GdmCl (M)  0.76 2.73 3.07 4.65 0.96 1.26 
SDS (%)  0.29 1.48 1.26 4.00 0.29 0.43 
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concentration (see Figure 3.30 A). For instance, at 5 M GdmCl, this single variant still 
retained slight activity, while other variants (except M6) lost their activities completely. 
Three variants with multiple substitutions, including M4, M5 and M6 have much 
improved IC50 values, indicating their tolerance towards GdmCl or SDS in terms of 
their activities were much improved. Especially M6, the most resistant variant towards 
chaotropes, showed almost 6 fold (WT: 0.76 M; M6: 4.65 M) and 14 fold (WT: 0.29 %; 
M6: 4.00 %) improved tolerance towards GdmCl or SDS, respectively. However, 
though M5 is slightly more tolerant than M4 towards GdmCl, but less tolerant towards 
SDS compared to M4.  
3.2.4.3 Activities towards the complex substrate Azocasein 
Azocasein was used as alternative to Skim-milk to quantify the proteolytic activities of 
subtilisin E variants. The activities of subtilisin E variants towards Suc-AAPF-pNA and 
Azocasein are listed in Table 3.32. 
Table 3.32 Specific activities and ratios of purified subtilisin E variants towards Suc-AAPF-pNA 
and Azocasein as substrates. 
Variants  
Suc-AAPF-pNA      Azocasein 
U/mg Ratio U/mg Ratio 
WT  24.6±0.3 1.00±0.01 486±24 1.00±0.04 
M4  42.8±0.7 1.74±0.03 172±1 0.35±0.00 
M5  111.4±2.0 4.53±0.08 257±3 0.53±0.01 
M6  136.1±1.7 5.53±0.07 182±10 0.38±0.02 
N218S  33.6±3 1.37±0.01 249±28 0.51±0.05 
T224A  39.5±3 1.61±0.01 196±3 0.40±0.01 
 
All purified subtilisin E variants in Table 3.32 lost more than half of their activities 
towards substrate Azocasein when compared to wild type. Activities of variants 
towards polypeptide substrate Suc-AAPF-pNA increased from 1.5 to 5.5 fold. 
However, the activities towards Azocasein were mostly even lower compared to ones 
towards Skim-milk as substrate (see Table 3.22), which can be attributed to the 
purification. Purified proteins are less stable than non-purified supernatants. In 
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addition, the Azocasein assay was performed at 37oC normally for 30 min or 60 min, 
while Skim-milk assay was performed at 37oC only for 15 min (see section 2.2.7). 
3.2.5 Stability of variants in the presence of GdmCl or SDS 
Stability of subtilisin E and its variants here in terms of their activities with time in the 
presence of various concentrations of GdmCl or SDS were investigated and half lives 
were determined to further evaluate their tolerance towards GdmCl and SDS.  
3.2.5.1 Study I: 1st round of SSM and recombination 
Figure 3.33 shows that all subtilisin E variants (Study I) are more stable in the 
presence of all concentrations of chaotropes when compared to the wild type. 
Subtilisin E wild type lost more than 50 % of its activity as soon as it was exposed to 
GdmCl or SDS (in less than 2 min), making a half life estimation challenging.  
    As seen in Table 3.34, in 3 M GdmCl the half lives are <2 min (wild type), <2 min 
(S62I), 5.7 min (G166M), 47.9 min (SeSaM1-5), 55.7 min (M2); Similar results are 
obtained for 2 M and 1 M GdmCl. M2 is especially at 3 M GdmCl significantly more 
stable than SeSaM1-5 (M4).  
    At 2 % SDS, the half lives are <2 min (wild type), 39.9 min (S62I), 14.5 min 
(G166M), 54.8 min (SeSaM1-5) and 44.4 min (M2). At 1 % SDS, the half lives are <2 
min (wild type), 1.6 h (S62I), 2.5 h (G166M), 1.5 h (SeSaM1-5) and 1.5 h (M2). At 0.5 % 
SDS, the half lives are 2 min (wild type), 2.9 h (S62I), 2.0 h (G166M), 2.7 h 
(SeSaM1-5) and 2.8 h (M2). The order of resistance of the four mutants depends in 
contrast to GdmCl highly on the employed SDS concentration. At 2 % SDS SeSaM1-5 
(M4) has the highest half life whereas M2 is more resistant than M4 in GdmCl (3 M).   
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Figure 3.33 Stability of purified subtilisin E wild type and its variants (Study I) in the presence 
of various concentrations of GdmCl or SDS by determining residual proteolytic activity 
(Suc-AAPF-pNA assay, 25
o
C). Relative activities were measured in triplicate and averaged 
with < 10 % standard deviation considering the activities in the absence of chaotropic agents 
as 100 %. Final protease concentration was 50 nM.  
 
Table 3.34 Half lives of purified subtilisin E and variants (Study I) in the presence of 
chaotropes. 
Variants 
GdmCl SDS 
1 M (h) 2 M (h) 3 M (min) 0.5% (h) 1.0% (h) 2.0% (min) 
WT <2 min <2 min <2 min 2 min <2 min <2 min 
S62I 0.4  <2 min <2 min 2.9  1.6  39.9  
G166M 4.0  1.7  5.7  2.0  2.5  14.5  
SeSaM1-5 4.7  1.7  47.9  2.7  1.5  54.8  
M2 5.4  1.4  55.7  2.8  1.5  44.4  
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3.2.5.2 Study II: 2nd round of SSM and recombination 
Figure 3.35 showed that, the same stability profile was observed for new variants 
constructed in Study II, except for M5 which was very unstable, although it still kept 
high resistance at beginning in the presence of chaotropes. In contrast, single mutant 
N218S, was extraordinarily stable in all cases, regardless its poor resistance towards 
chaotropes at beginning. However, M6 showed “highest” stability in GdmCl compared 
to SeSaM1-5 (M4), and almost the same stability in SDS in M4.   
     
 
Figure 3.35 Stability of purified subtilisin E wild type and its variants (Study II) in the presence 
of various concentrations of GdmCl or SDS by determining residual proteolytic activity 
(Suc-AAPF-pNA assay, 25
o
C). Relative activities were measured in triplicate and averaged 
with <10 % standard deviation considering the activities in the absence of chaotropic agents 
as 100 %. Final protease concentration was 50 nM. 
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    As seen in Table 3.36, in 5 M GdmCl, the half lives are <2 min (WT), <2 min 
(N218S), <2 min (T224A), 2.3 min (M4), 4.8 min (M5) and 15.2 min (M6). In 2.0 % 
SDS, the half lives are <2 min (WT), <2 min (N218S), <2 min (T224A), 77.3 min (M4), 
33.4 min (M5), and 66.3 min (M6).  
Table 3.36 Half lives of purified subtilisin E and variants (Study II) in the presence of 
chaotropes. 
Variants 
GdmCl SDS 
1 M (h) 2 M (h) 3 M (min) 5 M (min) 0.5% (h) 1.0% (h) 2.0% (min) 
WT <2 min <2 min <2 min <2 min 2 min <2 min <2 min 
N218S <2 min <2 min <2 min <2 min 2 min <2 min <2 min 
T224A <2 min <2 min <2 min <2 min 0.6 0.1 <2 min 
M4 4.0 1.0 17.0 2.3 2.0 1.5 77.0 
M5 3.1 0.8 18.1 4.8 1.0 0.7 33.4 
M6 6.4 2.3 67.6 15.2 2.4 1.3 66.3 
3.2.6 Analysis of structural stability 
Figure 3.37 showed the study of conformational changes of subtilisin E and its 
variants in GdmCl or SDS by analysis of circular dichroism (CD) spectra.  
    It is indicated that the structure of subtilisin E variants didn’t change obviously in 
the presence of 1-2 M GdmCl (except M4 at 2 M GdmCl), since the curves were very 
similar to the one in the absence (see Figure 3.37, left column). M4 seemed more 
unstable in GdmCl solutions and started unfolding from concentration of 2 M GdmCl, 
and was completely unstructured in 5 M GdmCl, while other variants started unfolding 
from concentration of 3 M GdmCl, and still kept its structure partially in the presence 
of 5 M GdmCl. In general, the order of structural stability in the presence of GdmCl is 
roughly as M6 > WT > M5 > M4.  
    The study of protein structure in protein-SDS micelle complexes by CD has been 
reported [118], in which two helical proteins had a slight loss in α-helix content. However, 
the structure of all subtilisin E variants in this dissertation remained almost unaltered 
in concentrations up to 50 mM SDS. It has been reported that the structure of 
subtilisin Carlsberg ist not perturbated by up to 400 mM concentration of SDS [119].  
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Figure 3.37 CD spectra analysis of subtilisin E and its variants in the presence of different 
concentrations of GdmCl or SDS. Purified subtilisin E WT, M4, M5 and M6 (300-500 ug/mL) 
were mixed with 0-5 M GdmCl or 0-2.0 % SDS (final concentration) and immediately 
measured at room temperature. The data were averaged by five scans.      
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The CD spectra results were not compatible with resistance of these variants in terms 
of IC50 and half life values. For instance, M4 was much more active in the presence of 
GdmCl compared with WT in 2 M, 3 M GdmCl (see Figure 3.30 and Figure 3.35), but 
CD spectra results showed that its secondary structure was unstable when compared 
to WT. This indicated the resistance had no direct correlation with their secondary 
structural stabilities. It could be speculated, at lower concentrations of GdmCl (1-2 M) 
or given concentrations of SDS, fast loss of activities was most likely not caused by a 
loss of secondary structure. However, the structural stability is still beneficial for 
improvement of resistance. M6, for instance, is more structurally stable in GdmCl than 
other variants, and showed much improved resistance (see Figure 3.30), which might 
be caused by the additional substitutions N218S and T224A.   
3.3 Computational analysis for chaotrope resistance 
This section focused on the study of the effects of GdmCl and SDS on subtilisin E by 
computational analysis, such as model building, molecular docking and molecular 
dynamics (MD) simulations. These analyses are very helpful to interpret or elucidate 
the mechanism indicated by the experimental results or propose some hypothesis 
which sheds lights on the profound mechanism of protein denaturation. However, 
protein denaturation is such a complex process, in which subtilisin E inactivation 
occurs prior to unfolding. The detailed analyses in this chapter also provide insights in 
how this inactivation occurs and why loss of activity could be compensated by those 
substitutions identified or generated in the last two sections. 
3.3.1 Model building of subtilisin E-substrate complex 
Different models, including wild type and other variants were built using FoldX [102]. 
The C-terminal of Pro-domain in the crystal structure was replaced and superimposed 
by the substrate Suc-AAPF-pNA in a protease-substrate manner, followed by energy 
minimization in vacuum (see section 2.2.14.1). This model building was an alternative 
of protease-substrate docking, since the attempts of docking of substrate Suc-AAPF-   
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Figure 3.38 Structures of subtilisin E wild type and variants bound to chromogenic substrate 
Suc-AAPF-pNA. Different amino acid substitutions obtained by directed evolution are labeled 
with the catalytic triad (blue) and substrate (red). In model of wild type (WT), beneficial 
substitutions are labeled in green (Study I) or cyan (Study II). In model of variants, 
substitutions are labeled in yellow (derived from M4) or other colors (additional substitutions).  
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-pNA was not successful due to its bulky volume and flexibility. Besides, the 
mechanism of hydrolysis and substrate binding of such substrate was determined and 
well-known, which has been used to construct models [36]. 
    Figure 3.38 displayed the models of subtilisin E-substrate complex for wild type 
and other variants, including SeSaM1-5 (M4), M2, M5 and M6. The conformation of 
substrate Suc-AAPF-pNA in all these models doesn’t show much difference except for 
a slight rotation of the benzene ring of phenylalanine caused by a mutation at position 
166. As mentioned previously, the beneficial substitutions for chaotolerance are 
mostly located in or close to the active site or substrate binding pockets, except T240. 
The substitutions at position 97 or 103 were excluded in these muteins.   
3.3.2 Docking of chaotrope in subtilisin E 
One molecule of chaotropic agent (guanidinium: Gdm+ or dedecylsulfate: DS-) was 
docked to the active site or substrate binding pockets of subtilisin E wild type and 
variants to investigate their most probable binding sites, in order to better understand 
their inactivation role as well as the difference between wild type and variants in 
respect to chaotolerance.  
3.3.2.1 Docking of guanidinium in Subtilisin E 
Docking of a single Gdm+ in the region of the active site and binding pockets revealed 
that Gdm+ was more prone to interact with essential residues in the active site or 
substrate binding pockets in wild type than other variants. The differences are most 
likely caused by substitutions in the variants.  
    Figure 3.39 showed two putative binding modes of Gdm+ in subtilisin E wild type 
and variants which ranked at first and second place in terms of their binding energy. 
Only in wild type, as shown in Conformation 1 in WT (Figure 3.39), the position shift of 
the active site residue H64 was observed. In addition, Gdm+ imbedded into the 
catalytic triad so that the active site was deformed. Conformation 2 in wild type 
showed the second possibility of binding site of Gdm+ which is located at the 
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specificity binding pocket and imbeded into the cleft. Very interestingly, in the single 
mutant S62I, imbedding of Gdm+ into the catalytic triad was not observed but in the 
specificity binding pocket cleft. However, in single mutant G166S, the opposite was 
observed. Additionally, both imbeddings were missing in muteins M4 and M6 which 
have both substitutions. These docking results highly indicate that most strong 
binding sites are either located in the catalytic triad or specificity binding pocket P1, 
and those substitutions at position 62 and 166 are beneficial for GdmCl tolerance. The 
latter is most likely caused by reducing Gdm+ binding by structural extension of their 
side chains. These results are in accordance with experimental results. Docking of 
other variants, such as N218S and T224A, resulted in similar observations (data not 
shown), which indicates other substitutions are not as effective as those discussed 
above. This is also supported by experimental results.  
3.3.2.2 Docking of dodecylsulfate in Subtilisin E 
Dodecylsulfate (DS-), as an amphiphilic anion of SDS, is supposed to have very 
different effects on proteins compared to Gdm+, like electrostatic interaction of its 
head group with charged residues and hydrophobic interaction of its tail group with 
hydrophobic residues as expected. However, experimental results indicated that the 
most beneficial substitutions for SDS tolerance (S62I and G166S) were, interestingly, 
at the same positions as for GdmCl resistance, located around the active site or 
substrate binding pocket. Results of docking of DS- on subtilisin E wild type and 
variants in this region showed less evident difference between wild type and variants 
than in the case of Gdm+ docking. This is most probably due to large size of ligand 
molecule and the highly flexible hydrophobic tail, which makes docking of DS- difficult 
to trace highly accurate conformation. However, it could be observed that the DS- 
molecule is slightly more away from the active site in variants compared to wild type 
(see Figure 3.40 Conformation 1). MD simulations are in this case recommended to 
investigate more details of SDS interaction with subtilisin E.  
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Figure 3.39 Conformation of Gdm
+
 binding to subtillsin E and its variants in the active site or 
substrate binding pockets after docking using Yasara program. Conformation 1 & 2 are two 
most possible binding site of Gdm
+
 (in sphere form) ranked by binding energy. Catalytic triad 
residues (D32, H64 and S221) are displayed in red. Substitutions are displayed in green (wild 
type), yellow (substitutions in study I) or orange (substitutions in study II). 
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Figure 3.40 Conformation of DS
-
 binding to subtillsin E and its variants in the active site or 
substrate binding pockets after docking using Yasara program. Conformation 1 & 2 are two 
most possible binding site of dedecylsulfate (in sphere form) ranked by binding energy. 
Catalytic triad residues (D32, H64 and S221) are displayed in red. Substitutions are displayed 
in green (wild type), yellow (substitutions in study I) or orange (substitutions in study II). 
3.3.3 MD simulations of GdmCl aqueous solutions 
Molecular dynamics (MD) simulations were performed to investigate effects of 
chaotropic salts, like GdmCl on both one model peptide melittin and the protease 
subtilisin E in order to understand its mechanism of inactivation and comparison to 
experimental results.  
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3.3.3.1 Alpha-helical peptide melittin 
A MD simulation of the model peptide melittin (26 amino acids) in 3 M GdmCl has 
been reported using CHARMM force field [73]. The simulation analysis indicated that 
Gdm+ can interact with a number of planar amino-acid side chains (Arg, Trp, Gln) in a 
stacking manner, as well as more weakly with hydrophobic surfaces composed of 
aliphatic side chains, and that these interactions result in enhanced number densities 
of Gdm+ at certain locations on the peptide surface. 
    Similar MD simulations of this model peptide melittin were run in different 
concentrations of GdmCl aqueous solution using the package for MD simulations 
Gromacs and GROMOS96 force field (see section 2.2.14.3) for comparison to the 
previous CHARMM simulation [73] and also to further provide insights into the effect of 
the concentration of Gdm+ on this peptide at a molecular level. 
    Therefore, MD simulations of melittin in water and three different concentrations 
of GdmCl (1 M, 3 M and 5 M) were run for 10 ns including 1 ns of equilibration. Root 
mean square deviations (RMSD) analysis (see Figure 3.41) showed conformation of 
mellitin in GdmCl was less stable than in water (average RMSD in water 0.22 nm, 1 M 
GdmCl 0.30 nm, 3 M GdmCl 0.28 nm, 5 M GdmCl 0.27 nm) during simulations (last 5 
ns). It is noticed that before 5 ns, RMSD was unexpectedly higher when melittin was 
in lower concentrations of GdmCl. After 5 ns, RMSD at all concentrations of GdmCl 
were very similar. In general, the conformation of melittin is less stable in molar 
concentrations of GdmCl solution than in water, but no rapid unfolding was observed 
(<0.5 nm).  
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Figure 3.41 RMSD analysis of a model peptide melittin in the presence of water (black), 1 M 
GdmCl (red), 3 M GdmCl (green) and 5 M GdmCl (blue) with respect to starting structure 
(backbone). The simulations were run at 298 K for 10 ns, in which the first 1 ns was used for 
annealing and the remaining 9 ns for analysis. 
    Secondary structure analysis revealed that GdmCl could partially unfold the 
α-helix of melittin during simulations (see Figure 3.42). Moreover, unfolding effect is 
more evident at higher concentration, though the helix still remains. A similar 
unfolding effect was observed for the peptide, magainin (23 amino acids), in different 
concentrations of GdmCl solution during MD simulations (GROMOS96 force field) [77]. 
However, the concentration effects of GdmCl using CHARMM force fields were to 
date not reported. 
    Strong interactions between Gdm+ and hydrophobic amino acids were observed 
throughout simulations at all concentrations of GdmCl, such as Trp19 (see Figure 
3.43) with respect to their distance. However, stacking with guanidine group of Arg 
was not observed in all cases which were different from the report using CHARMM 
force field [74].  
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Figure 3.42 Secondary structure analysis of melittin in water and different concentrations of 
GdmCl during MD simulations at 298 K by DSSP program 
[120]
.   
 
 
Figure 3.43 Snapshot of melittin structure throughout MD simulations in different 
concentrations of GdmCl with highlighted Trp19 (yellow) interaction with one Gdm
+
 ion in a 
stacking manner. Molecules within 0.5 nm of residue Trp19 are highlighted in green.  
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3.3.3.2 Subtilisin E 
A 50 ns long MD simulation running on subtilisin E in both pure water and 5 M GdmCl 
were performed in this work. In Figure 3.44 A, the backbone root mean square 
deviation (RMSD) values are reported in respect to the crystal structure for both 
simulations. In both simulations, RMSD curves reach an average plateau value of 
~0.15 nm. Furthermore, the analysis of the RMS deviations and fluctuations per 
residue (see Figure 3.44 B&C) show that the protein residues undergo a similar 
average conformation change and have similar motilities in both water and GdmCl 
solution with the only exception for the loop region 20-26. The apparent stability of the 
protein in the GdmCl simulation can be explained considering the expected time scale 
of the unfolding process. In fact, in a recent theoretical study, the unfolding of a 
lysozyme mutant (less stable than the wild type) in 8 M urea required a 1000 ns long 
MD simulations at 310K [80]. Considering also the recent experimental evidences for a 
more direct and faster mechanism of urea-induced than GdmCl-induced unfolding [121], 
it is unlikely to observe a GdmCl mediated unfolding event in this 50 ns long 
simulations. Nevertheless, it was evidenced from experimental data on many 
enzymes that the disturbance of GdmCl at the active sites occurred prior to 
conformational changes of the enzyme as a whole [122]. Gdm+ binding to subtilisin E in 
close proximity to the active sites can occur in time scales shorter than denaturation. 
Therefore our MD simulations can provide details for Gdm+ binding on subtilisin E.  
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Figure 3.44 Analysis of MD simulations of subtilisin E wild type in pure water (black) and 5 M 
GdmCl (red) at 298K for 50 ns. A) The root mean square deviations (RMSDs) with respect to 
starting structure (backbone). B) RMSD analysis per residue. C) The root mean square 
fluctuation (RMSF) analysis per residue. 
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    In Figure 3.45, the representation of spatial density function of Gdm+ ions is 
reported. The blobs in Figure 3.45 A, represent isosurfaces with high Gdm+ density 
and mainly localize in the active sites around the catalytic triad. The analysis of 
binding process during the simulation evidenced the following sequence of events. A 
first Gdm+ ion diffuses into the active site (after 21.8 ns of simulation) and binds to the 
catalytic triad residue by facing the imidazolium ring towards His64 and by forming 
two strong hydrogen bonds, one with Ser221 and one with Asp32 (see Figure 3.45 B). 
As shown in the same figure, the presence of Gdm+ in the active site weakens the 
hydrogen bonding between His64:Nε2 and Ser221:Oγ which is essential for 
proteolytic activity. Two additional Gdm+ ions are observed to diffuse in the active site 
during the simulation time (50 ns; see Figure 3.45 B) surrounding the active site 
residue in a similar way as the first Gdm+. Besides, Gdm+ ions are also observed to 
accumulate in the substrate binding pocket P1, where residue Gly166 is located (see 
Figure 3.46). Gdm+ ions might interact with Gly166 as well blocking the substrate 
specificity pocket of subtilisin E. Interestingly, all these observation are consistent with 
the results from docking (see section 3.3.2.1). 
    Furthermore, these results suggest that Gdm+ ions are strongly bound to the 
active site residues weakening H-bond networks (see Figure 3.45 B) which might 
cause a very fast inactivation of subtilisin E and provides a possible explanation for 
increased tolerance of the variant S62I whose substitution is located next to His64, 
which is also discussed in previous sections (see section 3.3.1 and section 3.3.2). 
 
 
Chapter 3 - Results 
92 
 
 
Figure 3.45 Analysis of Gdm
+
 coordination in MD simulation of wild type subtilisin E (5 M 
GdmCl). A) Active site region of wild type subtlisin E with distribution of Gdm
+
 ions during last 
25 ns simulation time by using a g_spatial program. Catalytic triad residues (Asp32, His64 and 
Ser221) are labeled. The Gdm
+ 
counters in the active site of subtilisin E are highlighted (arrow). 
B) Changes in the lengths of hydrogen bonds between Gdm
+
 (Nitrogens, N2 and N8) and 
Asp32 (Oδ1), Ser221 (Oγ), and between His64 (Nε2) and Ser221 (Oγ) during the 50 ns 
simulation. Three snapshots of catalytic triad with one Gdm
+
 ion (left, 10.8 ns; right, 37.6 ns) 
show a transition state after 21.8 ns (middle) that results in Gdm
+
 bond-flip to Asp32 and 
Ser221 at the active site. In the snapshot of transition state (middle), catalytic triad and residue 
62 are labeled and displayed in red (at 21.8 ns, before transition) and blue (at 21.9 ns, after 
transition). Adjacent Gdm
+
 ions are displayed in yellow (at 21.8 ns) and green (at 21.9 ns).The 
arrow points out the transition switch of His64.  
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Figure 3.46 Binding pocket 1 region (P1) of wild type subtlisin E with distribution of Gdm
+
 ions 
during last 25 ns simulation by using a g_spatial program. The subtilisin E backbone is 
displayed in gray. Residue Gly166 is displayed in licorice format and labeled. The Gdm
+
 
counters are displayed in solid surface format in green. 
    Finally, variation on the secondary structure distribution over simulation time was 
analyzed (see Figure 3.47) which showed no evident changes of α-helix and β-sheet 
during 50 ns simulations in water and 5 M GdmCl, which is different from the analysis 
reported for the model peptide melittin (see Figure 3.42). This might be due to the size 
of protein (melittin, 26 aa; subtilisin E, 275 aa) and limited simulation time scale 
(nanosecond scale). MD simulations at elevated temperature, such as 350K or 400K, 
could accelerate destabilization of secondary structure as reported for another small 
protein Protein L (62 aa) [74]. 
 
Figure 3.47 Secondary structure analysis of wild type subtilisin E in water and 5 M GdmCl 
during MD simulations at 298K for 50 ns by DSSP program.  
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    MD simulations of subtilisin E wild type at three different concentrations were also 
performed to investigate their effects. Coordinate of subtilisin E were taken for setup 
of these simulations after equilibrium in pure water for 25 ns at 298K in order to 
exclude potential inappropriate structure conformation in the crystal structure, since 
this wild type model was generated from an inactive Pro-subtilisin E complex. Figure 
3.48 A showed that the RMSD of subtilisin E wild type under all conditions converged 
at ~0.15 nm. However, the RMSD in 1 M GdmCl is very similar to the one in water, 
while RMSD in 3 M GdmCl keeps constant around ~0.12 nm after 7 ns. Different from 
1 M and 3 M GdmCl simulations, RMSD gradually increases in the case of 5 M GdmCl. 
RMSF analysis shows that fluctuation of residues is almost the same in water and 1 M 
GdmCl, while fluctuation modes are similar in 3 M and 5 M GdmCl (see Figure 3.48 B). 
Additionally, the radius of gyration (Rg) slightly decreases in all cases, but decreases 
less slowly in higher concentrations of GdmCl (see Figure 3.48 C), indicating the 
compactness of conformation throughout MD simulations.  
    Spatial distribution function (SDF) analysis of Gdm+ ions throughout all 
simulations of wild type subtilisin E in 1 M, 3 M and 5 M GdmCl showed a constant a 
blob around the catalytic triad residues regardless of GdmCl concentrations (see 
Figure 3.49 left column). The distance between such a blob and the center of active 
site is slightly shorter in higher concentration of GdmCl (see Figure 3.49 right column). 
This can be considered as a strong indication that strong binding of Gdm+, even at a 
lower concentration. It could be the reason for an inactivation of subtilisin E, and the 
strong binding occurrs on initial phase which also reveals that such inactivation can 
be extremely fast. Besides, it is also observed that higher concentrations could evoke 
such binding earlier than lower concentrations (1 M: ~5.0 ns; 3 M: ~3.5 ns; 5 M: ~1.0 
ns) indicated by monitoring the distance between a strong binding Gdm+ and the 
center of catalytic triad (see Figure 3.50) during simulations. All these observations 
are supported by experimental results in section 3.2.5.  
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Figure 3.48 Analysis of MD simulations of subtilisin E wild type in pure water (black), 1 M 
GdmCl (red), 3 M GdmCl (green) and 5 M GdmCl (blue) at 298K for 25 ns. A) RMSD with 
respect to starting structure (backbone). B) RMSF analysis per residue. C) Radius of gyration 
(Rg) analysis. 
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    It is noticed that strong bounded Gdm+ could be also released after a certain time, 
as seen in Figure 3.50 for simulations in 1 M and 3 M GdmCl, which indicates a 
competitive inhibition effect at lower concentrations of GdmCl onsubtilisin E. However, 
imbedding of Gdm+ into the active site did not reposite His64, as shown in Figure 3.45. 
These new simulations were performed at varied parameters in a shorter time (25 ns).   
 
Figure 3.49 Analysis of Gdm
+
 coordination in MD simulations of wild type subtilisin E in 
different concentrations of GdmCl. A) 1 M GdmCl; B) 3 M GdmCl; C) 5 M GdmCl. The left 
column displayed wild type subtlisin E (backbone in grey) with distribution of Gdm
+
 ions during 
last 20 ns simulation time by using a g_spatial program. Catalytic triad residues are highlighted 
in red. The Gdm
+ 
counters in the active site of subtilisin E are highlighted in the yellow box and 
zoomed in right column, where catalytic triad residues are displayed in yellow (Asp32), blue 
(His64) and red (Ser221).   
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Figure 3.50 Distance between one strong binding Gdm
+
 and center of catalytic triad during 
MD simulations of wild type subtilisin E in different concentrations of GdmCl. The distance was 
measured between carbon atoms of Gdm
+
 and His64 as showed in a snapshot above the 
curve. 
    The tetramutant M4 was also considered for MD simulations in both pure water 
and 5 M GdmCl to investigate the effects of substitutions on subtilisin E tolerance 
towards GdmCl on the molecular level. RMSD analysis of M4 in water and 5 M GdmCl 
for 25 ns is compared to those of wild type (from 50 ns simulations). Figure 3.51 
shows there are almost no differences in RMSD during 25 ns simulations in wild type 
or M4 in water and 5 M GdmCl, indicating that there would be no conformation 
differences between wild type and M4 in respect to their structure as a whole.  
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Figure 3.51 RMSD analysis of MD simulations of subtilisin E variants with respect to starting 
structure (backbone) in water (WT: black; M4: green) and 5 M GdmCl (WT: red; M4: blue).  
    RMSF analysis shows that fluctuation of both WT and M4 in water is almost the 
same, and M4 has less fluctuation in many regions, like Loop2, except Loop1 (see 
Figure 3.52 A). Conformations of both WT and M4 from each 2.5 ns were clustered as 
showed in Figure 3.52 B, which shows very obviously the difference of fluctuation in 
Loop1 and Loop2 in both variants along 25 ns simulations. It is supposed that such 
difference is most likely caused by mutations at position 166 in Loop2, as discussed 
previously by extension of side chain to expel Gdm+ binding, but however also affect 
the flexibility of Loop1.     
    Furthermore, SDF analysis of Gdm+ binding in Figure 3.53 showed a blob of 
Gdm+ were also found around the catalytic triad. However, Gdm+ binding seems to be 
blocked due to “shrinked” local surroundings so that Gdm+ couldn’t further reposite 
residues in the active site. Besides, His64 becomes more rigid in M4 due to 
substitution S62I, while substitution G166S might have effects on Loop1 to indirectly 
interference the binding of Gdm+ to the active site, as mentioned previously.  
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Figure 3.52 Fluctuation analysis of MD simulations of subtilisin E variants in water (WT: black; 
M4: green) and 5 M GdmCl (WT: red; M4: blue). A) RMSF. B) Cluster of structures of subtilisin 
E variants in 5 M GdmCl. Each 2.5 ns frame was aligned in a cluster. Loop1 (residue 125-130) 
and Loop2 (residue 155-165) are labeled. Catalytic triad residues are displayed in red, and 
positions of substitutions are highlighted in green (WT) or yellow (M4).   
 
Figure 3.53 Analysis of Gdm
+
 coordination in MD simulations of subtilisin E variants in 5 M 
GdmCl. A) WT; B) M4. Top row displayed wild type subtlisin E (backbone in grey) with 
distribution of Gdm
+
 ions during 25 ns simulation by using a g_spatial program. Catalytic triad 
residues are highlighted in red. Gdm
+ 
counters in the active site of subtilisin E are highlighted 
in the yellow box and zoomed in the lower row, where catalytic triad residues are displayed in 
yellow (Asp32), blue (His64) and red (Ser221). The visible substitutions were also labeled.   
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3.3.4 MD simulations of subtilisin E in the presence of SDS 
aqueous solutions 
MD simulations were performed on subtilisin E wild type in the presence of SDS 
molecules. Two different concentrations at 1 % (w/v) and 5 % (w/v) were taken into 
account in order to investigate SDS concentration effects on subtilisin E. As seen in 
Figure 3.54, the RMSD in water and two SDS solutions show a similar trend with the 
two curves from SDS slightly lower than the one from the water simulation. 
Interestingly, the same trend was observed in the case of GdmCl simulations 
regardless of different chaotrope type and their concentration (see section 3.3.3.2). 
 
 
Figure 3.54 RMSD analysis of MD simulations of subtilisin E wild type with respect to starting 
structure (backbone) in water (black), 1 % SDS (red) and 5 % SDS (green).   
    The RMSF per residue (see Figure 3.55 A) reveal there are almost no changes in 
the residue flucturation in water, 1 % and 5 % SDS simulations. Essential dynamic 
analysis [113] was performed to further investigate the type of collective modes present 
in different proteins. As seen in Figure 3.55 B, three most representative motion 
modes (first 3 eigenvectors) were taken for comparison, which reveals in general that 
three essential motions are different in the three simulations.   
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Figure 3.55 RMSF analysis of MD simulations of subtilisin E wild type in water (black), 1 % 
SDS (red) and 5 % SDS (green). A) RMSF per residue with respect to starting structure 
(protein). B) RMSF per residue obtained by projecting trajectories on the corresponding first 3 
eigenvectors. 
    Secondary structure analysis shows that there are still no evident changes in 
simulations of subtilisin E wild type in water and SDS solutions (see Figure 3.56).  
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Figure 3.56 secondary structure analysis of wild type subtilisin E in water, 1 % SDS and 5 % 
SDS during MD simulations at 298K for 25 ns analysed by DSSP program. 
    When monitoring the minimum distances between all SDS molecules and protein, 
it is observed that in SDS simulations at both concentrations almost all SDS 
molecules were bound to the protein (< 0.6 nm) rapidly (in 5 ns). Additionally, all SDS 
molecules were strongly bound and didn’t separate from the protein again, especially 
in 1 % SDS simulation (see Figure 3.57). 
 
Figure 3.57 Minimum distances between all SDS molecules and subtilisin E wild type during 
25 ns MD simulations in SDS. A) 1 % SDS (7 SDS molecules). B) 5 % SDS (32 SDS 
molecules). The minimum distances between selected groups were calculated using program 
g_mindist. 
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Figure 3.58 Snapshots of MD simulations of subtilisin E wild type in SDS solutions. Snapshots 
at 0 ns, 5 ns, 10 ns and 25 ns were displayed with subtilisin E in trace format and SDS 
molecules in VDW format. All water molecules in all snapshots are not shown for better 
visualization.  
    However, micelles were observed along simulation in 5 % SDS but not in 1 % 
SDS (see Figure 3.58). At 0 ns in 5 % SDS simulation, 32 SDS molecules were randomly 
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distributed around subtilisin E after equilibrium. The first three micelles were observed in 
less than 5 ns which consisted of 4, 5, 6 SDS molecules respectively, and one SDS 
molecule was attached to subtilisin E surface. After 5 ns, two micelles were attached to 
the protein surface. At 10 ns, 3 micelles were attached, while one of them consisted of as 
many as 11 SDS molecules. At 25 ns, 4 micelles were attached to the subtilisin E surface.   
    The mutant M4 was also set up for MD simulations in water and 5 % SDS, in 
order to investigate the effects of substitutions on its tolerance towards SDS, 
compared to wild type. RMSD analysis of M4 in 5 % SDS showed a slightly higher 
deviation than in water along 25 ns simulation, while WT showed a higher deviation in 
water (see Figure 3.59). However, in general, RMSD values are all less than 0.15 nm, 
indicating that there are no evident conformational changes in all cases. 
 
Figure 3.59 RMSD analysis of MD simulations of subtilisin E variants with respect to starting 
structure (backbone) in water (WT: black; M4: green) and 5 % SDS (WT: red; M4: blue). 
    Essential dynamic analysis was applied to better investigate the fluctuation 
patterns of both wild type and M4 in the presence of 5 % SDS, as showed in Figure 
3.60. The results show that two motions in both cases are dominant: one has average 
fluctuations all over the structure, and the other has a high fluctuation only in one loop 
(residue 155-165), while the positions at substitutions in both cases are very similar in 
terms of their fluctuation (see Figure 3.60 A). However, in both modes, M4 seems to 
fluctuate more than wild type subtilisin E (see Figure 3.60 B).  
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Figure 3.60 RMSF analysis of MD simulations of subtilisin E variants in 5 % SDS. A) RMSF 
per residue obtained by projecting trajectories on the corresponding first 3 eigenvectors. Four 
helical strip lines (green) indicated the positions of substitutions in M4. B) Structure clusters of 
first 3 eigenvectors.  
    Analysis of interaction of subtilisin E variants with cosolvents showed that the 
number of hydrogen bonds between protein and SDS increased faster in M4 
compared to WT in the first 5 ns and kept constant as in the case of WT (see Figure 
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3.61 A). Analysis of the solvent accessible surface area (SASA) showed in both cases 
that the accessible areas decreased fast during the first 5 ns mostly due to shielding 
by SDS binding. However, the accessible areas are less in M4 than in WT when the 
number of SASA keeps constant (see Figure 3.61 B), which indicates that surface 
area is less accessible in M4 than in WT.  
 
Figure 3.61 Analysis of subtilisin E variants (WT and M4) on interaction with cosolvents during 
25 ns MD simulations in 5 % SDS. A) Hydrogen bonding of subtilisin E variants with SDS 
molecules. B) Solvent accessible surface area (SASA) of subtilisin E variants.   
    Spatial distribution of hydrophilic head and hydrophobic tail of dodecylsulfate was 
analyzed (see Figure 3.62). The results showed that the binding of SDS in WT and M4 
was similar. The area of the active site and substrate binding pockets are highlighted 
and it is more likely, the SDS molecules are slightly positioned away from these areas 
when M4 is compared to WT, which might be due to the substitutions.   
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Figure 3.62 Analysis of SDS coordination in MD simulations of subtilisin E variants in 5 % 
SDS. Analysis of spatial distribution function (SDF) was performed into two groups: hydrophilic 
head group (left column) and hydrophobic tail (right column). The active site and substrate 
binding pockets are highlighted in the circle. Catalytic triad residues are displayed in red, and 
substitutions are also highlighted in green/blue (WT) or purple (M4).   
    Future examination along the whole simulations of both WT and M4 shows that, 
SDS molecules can bind to essential area for activity, such as the active site or the 
substrate binding pockets. As seen in Figure 3.63, two or three SDS molecules were 
stick to the active site or the substrate binding pocket in 25 ns simulations. For 
instance, in MD simulation of WT, hydrophilic head group of SDS1 was bound to Q103 
in an unspecific binding pocket (Q103:Nε2-SDS1:OA), while hydrophobic tail was 
imbedded into the cleft. Besides, hydrophilic head group of SDS2 was strongly bound 
to N155 through hydrogen bonding (N155:Nδ2-SDS2:OA) which is essential for 
oxyanion hole stabilization. The hydrophobic tail of SDS3 was imbedded into a cavity 
between the catalytic triad and Y217 through mostly hydrophobic interactions. 
Nevertheless, SDS binding to Q103 and N155 was also observed in M4 simulations 
despite that the conformations of these SDS molecules were different.   
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Figure 3.63 Changes in the interaction between SDS and residues at active sites or substrate 
binding pocket during the 25 ns simulation of subtilisin E WT (A) or M4 (B). Snapshot of SDS 
binding on WT (10.0 ns) or M4 (14.7 ns) show that there are several SDS molecules which are 
stick to residues either at the active site or the substrate binding pocket. The interaction 
between them is plotted in terms of distance of selected atoms. Catalytic triad residues (black), 
SDS molecules (cyan), SDS-interactive residues (green) and substitutions (yellow) are 
labeled.  
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    However, Simulations (Figure 3.63) show that the active site are slightly away 
from interactions with SDS in M4 compared to WT, which might be due to “shrinkage” 
of the active site or substrate binding areas caused by substitutions (such as S62I, 
G166S). All these results are very similar to the observation in GdmCl simulations in 
which the local areas of the active site and substrate binding pockets are also 
supposed to be “shrinked” caused by the same substitutions to reduce Gdm+ binding.
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4. Discussion  
This dissertation describes many aspects of inactivation/denaturation of protease in 
the presence of chaotropes (GdmCl or SDS in this case) and the feasibility to evolve 
proteases to tolerate chaotropes by protein engineering. However, the 
inactivation/denaturation of enzymes by the chaotropic molecules resulted in a 
multifaced mechanism and detailed picture of the whole process is still not completely 
clear. Here we focus on the initial inactivation of subtilisin E and try to explain or 
propose a hypothesis on governing principles for chaotrope resistance, effects of 
substitutions we identified towards chaotrope resistance and for the 
activation/denaturation of subtilisin E.  
4.1 Directed evolution of proteases for chaotrope 
resistance  
To our knowledge, there are very few publications about directed evolution of 
enzymes for chaotrope resistance. Especially this dissertation is the first directed 
evolution approach applied for increasing protease tolerance towards GdmCl by 
directed evolution. Besides, only two reports exit on improving detergent resistance of 
hydrolases by directed evolution or semi-rational design. In a first report several 
rounds of in vivo gene shuffling in yeast are applied to a T. lanuginose lipase to 
improve its stability in the presence of the commercial detergents. Several strongly 
improved variants were obtained [123]. In the second report Danielsen and coworkers 
selected nine amino acids in the hinge region of the lipase “Lipolase” to overcome 
inhibitory effects in the presence of detergent. Despite proving that the display 
systems yielded enriched populations no improved variant could be isolated [124]. 
However, there is a strong practical aspect to the understanding what drives protein 
inactivation or unfolding in the presence of a detergent due to its broad industrial 
application. Companies such as Novozymes and Genencor have built up an 
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enormous empirical database of mutations that affect enzyme stability und 
performance in the detergent industry, but very few were published [52].  
4.2 Effects of substitutions on chaotrope resistance 
Model analysis for the single mutants (see Figure 4.1) revealed that most 
substitutions could slightly change the local area of the active site or substrate binding 
pockets. For instance, substitution S62I affects the rotation of imidazole ring of 
catalytic triad residue His64 by extending the side chain; substitution G166S or 
G166M affect the specificity binding pocket P1; substitution Q103P or Q103D affects 
the unspecific binding pocket P4.  
 
Figure 4.1 Substitutions of single mutants aligned with wild type. A) S62I; B) D97A; C) Q103P 
or Q103D; D) G166S or G166M; E) N218S; F) T224A. Wild type is displayed in grey. Single 
substitutions are displayed in yellow or green. Conformational changes of adjacent residues 
are displayed in red (substitutions in yellow) or blue (substitutions in green). All models of 
single mutant were generated based on wild type by Model Build module of FoldX.  
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    To date, almost all beneficial residues in subtilisin E here (see Figure 4.1) have 
been reported in its homologs for different properties [6]. Substitution at position 62 
which is located at the P2 site was responsible for substrate specificity. It’s been 
reported that systematic shifts in substrate specificity (kcat/Km) towards basic residues 
and away from the natural preference for hydrophobic substrates were observed by 
mutating neutral residues to negative charged residues (Glu or Asp) at position 62 or 
166 in subtilisin BPN’. The double mutant (N62D/G166D) had a larger than additive 
shift in specificity from hydrophobic to dibasic substrates [125]. However, different from 
other subtilisin homologs, Ser locates at position 62 in subtilisin E. Serine was 
mutated into Ile as “best” substitution in terms of GdmCl or SDS tolerance (see Table 
3.17), and affects His64, as showed in Figure 4.1 A. It could be assumed this effect 
might play the main role in GdmCl or SDS tolerance rather than strongly interactions 
with the substrate to change its specificity (see Table 3.29).    
    Substitutions at position 166 have been extensively studied for its importance in 
substrate specificity. It is reported that replacement of conserved glycine by other 12 
nonionic amino acids resulted in large changes in specificity towards substrates of 
increasing size and hydrophobicity. The catalytic efficiency (kcat/Km) towards small 
hydrophobic substrates was increased by hydrophobic substitutions, but dropped by 
enlarging either the substrate side chain or the side chain at position 166 due to steric 
hindrance [126]. Moreover, replacement of charged amino acids at this position resulted 
in increase of catalytic efficiency towards charged substrates [125-126]. Interestingly, 
substitution G166S in subtilisin BPN’ proved to improve its thermostability, since the 
half life of thermal inactivation was doubled in double mutant N218S/G166S (740 % 
wild type at 65oC) compared to single mutant N218S (350 % wild type at 65 oC) [127]. 
Thus that could be explained for subtilisin E M6 in this dissertation, which includes the 
same substitutions, and has significantly improved chaotrope tolerance (IC50 in 
GdmCl: WT, 0.76 M; M4: 2.73 M; M6: 4.65 M). Additionally, the same substitution was 
found in a hyperthermostable homolog TK-subtilisin as well, which is previously 
mentioned to retain full activity in chaotropic agents [128]. Another substitution G166M 
was considered as the “best” individual substitution in this dissertation regarding its 
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chaotrope tolerance (see Table 3.17), which was included in mutant M2. 
    Substitutions at position 218 have been investigated in subtilisin BPN’ regarding 
that effect on thermostability. The same substitution from Asn to Ser proved to 
account for enhanced thermostability due to stronger hydrogen bonding between two 
β-sheets [129]. Interestingly, the stability of a double mutant N109S/N218S from 
aprA-subtilisin, besides its 7 degree higher transition temperature than wild type, was 
also improved in the presence of SDS as a “side effect” [130]. In the protein engineering 
of subtilisin E, N218S was found not only responsible for higher thermostability [94], 
and notably also proved for increased activity as well as stability in the presence of 
organic solvent dimethylformamide (DMF) [131]. In this work, such substitution was 
generated by random mutagenesis and proved later to be the only one at this position 
improving chaotrope tolerance (see Table 3.17), which indicates N218S could be a 
general beneficial substitution for increased stability of subtilisins.  
    The substitution at position 224 in a double mutant of subtilisin BPN’ was 
reported for new activity as a subtiligase for ligation of peptides after screening of 
different libraries using phage display [132]. Thus it could be assumed that the 
substitution at this position might affect the catalytic triad residue Ser221 in proximity 
through surrounding hydrogen bonding networks. In this dissertation, some 
substitutions at position 224, such as T224A in subtilisin E showed improved 
chaotolerance (see Table 3.17) might work in the same manner. Interestingly, another 
beneficial substitution, T224S, was also found in other natural subtilisins, such as 
subtilisin BPN’ and subtilisin Carlsberg. Nevertheless, more studies are required for 
further elucidation of its chaotolerance contribution. 
    Substitution D97G was reported in subtilisin E for improving activity in organic 
solvent DMF [41], while we reported that the substitution D97A was responsible for 
moderate improved tolerance towards SDS (see Table 3.22). From Figure 3.38 and 
4.1 B, this substitution is supposed to exert effects on the loop region which binds the 
tetrapeptide substrate Suc-AAPF-pNA and improves activity towards SDS.  
    Position 103 on the surface of subtilisin E is very interesting for chaotrope 
tolerance in subtilisin E, because of its dual role for GdmCl and SDS tolerance (see 
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Table 3.22). Reports regarding substitution Q103R describe its role in improving 
activity in organic solvent DMF [41] due to a favorable electrostatic interactions 
between positive charged side chain of substituted Arg and negative charged 
protection succinyl group of substrate Suc-AAPF-pNA. However, another report 
stated that Q103R enhanced the specific activity of subtilisin E but decreased the 
thermal stability [133]. However, on one hand, it was found GdmCl tolerance was 
obviously improved by introduction of negative charged residues as in Q103D, Q103E 
mutant (see Table 3.17), which occur more often in halophilic counterparts [134]. It 
could be explained that excessive positive charged Gdm+ ions were trapped at this 
site through electrostatic interaction so that inner essential active residues were 
shielded. However, activities of both single mutants (Q103D and Q103E) were 
dramatically reduced due to unfavorable electrostatic interactions with the succinyl 
group of the substrate Suc-AAPF-pNA. On the other hand, substitution Q103P was 
selected from epPCR libraries for improvement of SDS tolerance (see Table 3.17), 
which might be caused by an elimination of hydrogen bonding in this region which 
also has an effect on the local structure of substrate binding site (see Figure 4.1 C). 
    Some other individual substitutions in muteins are mostly neutral in terms of their 
tolerance, such as I205V, A153V or T240S (see Figure 3.19 and Figure 3.21). 
Additionally, single mutant A153V seems to recover the activity towards complex 
protein substrate, while I205V seems detrimental (see Figure 3.19). However, A153V 
and I205V together improved SDS tolerance in M4 compared to M2 (see Figure 3.19). 
4.3 Inactivation and denaturation of enzymes 
In the study of chaotolerance improvement of subtilisin E by directed evoultion in this 
dissertation there are several results which are beyond our expectations: 1) it is 
observed that subtilisin E wild type lost their activity dramatically and instantly when 
exposed to GdmCl solutions even at lower moler concentration like 1 M (see Figure 
3.33), which came to the assumption that it might be caused by the direct disruption of 
conformation of this enzyme at lower concentration, especially the active site. 2) All 
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substitutions which are responsible for GdmCl- or SDS-resistance are located around 
the active site or substrate binding pockets of subtilisin E and these substitutions are 
mostly buried in the interior, not at the more accessible surface areas where they were 
normally reported for thermostability 
[39]
 or even tolerance in organic solvent like DMF 
[36]. Table 4.2 lists relative solvent accessibility (ASA) values of substitutions of 
subtilisin E variants after directed evolution under three different denaturant 
conditions, including temperature (thermostability), organic solvent like DMF and 
chaotropic agents like GdmCl or SDS (this project). Average ASA values are 55.7 % 
(Thermostability), 38.2 % (DMF tolerance) and 14.7 % (GdmCl/SDS tolerance), 
indicating that the substitutions for chaotolerance are least accessible and located in 
the interior. 3) It is unexpected that the several substitutions, such as S62I or G166S, 
could improve tolerance towards chaotropic salts (GdmCl) and detergent (SDS) 
simultaneously, which reveals that there might be some common pathways.  
    During the directed evolution of protease for its GdmCl- or SDS-resistance, 
comparatively lower concentrations of GdmCl (1 M) or SDS (0.5 %) were applied due 
to feasibility of screening system (higher concentration of denaturants induce 
complete loss of activity of WT). The effects of such low concentrations of GdmCl 
have been less studied since high concentrations (5-6 M) were mostly studied and 
used to denature proteins. GdmCl causes mostly conformational changes, as is also 
observed by circular dichroism results (see Figure 3.37). Tsou has reported in 1995 
one review about a very important observation that inactivation precedes overall 
molecular conformation changes during enzyme denaturation [122b]. In this review, it is 
mentioned that such observation has been found for 18 different enzymes. It is noted 
that the initial rates of inactivation of a number of enzymes in GdmCl or urea are 
usually too fast to be measured by the conventional method of incubation of enzymes 
with the denaturants. With stopped flow measurements, the inactivation rates of 
creatine kinase during GdmCl or urea denaturation were over three orders of 
magnitude faster than the rates of conformational changes under the same 
denaturant concentrations [135]. This is consistent with the observation that  
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Table 4.2 Relative solvent accessibility (ASA) of substitutions of best subtilisin E variants for 
stability under different denaturing conditions after directed evolution 
 
Residue  
Index 
Relative ASA* value (%) 
Themostability  
(5-3H5)
[39]
 
DMF tolerance 
(13M)
[36]
 
GdmCl/SDS tolerance 
(M6) 
14 29.6 - - 
48 - 21.8 - 
60 - 9.0 - 
62 - - 17.9 
76 65.6 - - 
97 - 20.8 - 
103 - 12.3 - 
107 - 1.1 - 
118 83.3 - - 
131 - 30.5 - 
153 - - 0.0 
156 - 74.4 - 
161 93.0 - - 
166 3.8 - 3.8 
181 21.9 21.9 - 
182 - 65.7 - 
188 - 85.3 - 
194 83.6 - - 
205 - - 1.6 
206 - 48.7 - 
218 64.9 64.9 64.9 
224 - - 0.0 
255 - 40.4 - 
Average  55.7  38.2  14.7  
*ASA values were calculated with ‘‘ASA view’’ (http://www.netasa.org/asaview/). The calculation is based 
on the crystal structure of subtilisin E (PDB code: 1SCJ) 
 
conformation changes of subtilisin E wild type in GdmCl revealed by CD spectra 
analysis (see Figure 3. 37) were much slower than the activity loss measured for half 
life of subtilisin E muteins (see Figure 3.33).  
    Thus three possibilities were proposed for such observation: 1) an inhibition of 
the enzyme by the chaotropes; 2) dissociation of the dimeric enzyme into the inactive 
monomers and 3) conformation perturbation at a relative flexible enzyme active site. 
Since subtilisin E is a monomer, the possibility of the dissociation of the dimeric 
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enzyme could be ruled out. Therefore inactivation prior to unfolding is either caused 
by inhibition of those chaotropes or conformational disruption of the active site.  
    There are some reports which favored the inhibition mechanism. For 
instance,GdmCl inhibits RNase A [136] since the decrease in enzyme activity in dilute 
GdmCl solution is a reversible inhibition at the active site [137]. Wu and coworkers 
reported on α-glucosidase inactivation at lower concentrations of GdmCl or SDS 
directly considered both to act as inhibitors [59]. Table 4.3 lists the residual activities of 
wild type and variant M4 in 1-2 M GdmCl or 0.5 % SDS on different concentrations of 
peptide substrate Suc-AAPF-pNA to indicate competitive inhibition mode.  
    Tsou in the review argued that the possibility of inhibition could be excluded. 
Some reports claim that thermal inactivation precedes heat induced conformation 
change such as for adenylate kinase [138], D-glyceraldehyde-3-phosphate 
dehydrogenase [139] and β-galactosidase [140]. A number of monomeric enzymes, such 
as lysozyme and Thermolysin, during pressure denaturation showed inactivation prior 
to unfolding [141]. In these cases, there was no inhibitor involved so that the inhibition 
by an inhibitor being responsible for the loss of enzyme activity can be excluded. It is 
also pointed out in some literature that as the denaturant is usually diluted many folds 
with the enzyme in activity assays, some refolding and hence reactivation may have 
occurred with sharp decrease at denaturing concentrations [142]. Furthermore, it is also 
mentioned in the review by Tsou that the presence of substrates in the assay mixture 
can sometimes cause reactivation especially for partially inactivated enzymes as the 
initial stage of unfolding. Another method to directly demonstrate that conformation 
changes at the active site under mild denaturing conditions causing inactiviation is by 
probing the active site with fluorescent probes. One fluorescent isoindole derivative 
was introduced as a probe near the active site of creatine kinase [143] and the results 
suggested increased mobility of the fluorophore at the active site.  
    In this dissertation, the perturbation of the active site by Gdm+ ions was also 
observed in one 50 ns MD simulations of subtilisin E wild type in 5 M GdmCl and the 
active site was disrupted by one “attacking” of one Gdm+ ion which replaced the 
position of the His64 (see Figure 3.45). However, other simulations of GdmCl and 
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SDS showed only strong binding instead of a disruption of the active site. Hence 
these two different interpretations for the inactivation prior to unfolding in chaotropes 
might be both reasonable, while the experimental and computational analysis in this 
dissertation might be in more favor of inhibition interpretation. 
    Nevertheless, it has previously been proposed that Gdm+ binding occurs at the 
active site of subtilisin E prior to molecular conformational changes, as indicated by 
MD simulations. Substitutions that dramatically decrease Km (see Figure 3.29) often 
increase affinity to the peptide substrate (Suc-AAPF-pNA), and reduce the flexibility of 
the active site. Therefore, tight substrate binding assists in excluding GdmCl from the 
active site, thereby resulting in increased GdmCl resistance. However, the activity 
with complex substrates, such as Skim-milk, was often reduced (Figure 3.19) due to 
decreased flexibility of the active site. Similar stabilization against denaturation in 
dilute GdmCl was observed in muscle lactate dehydrogenase H4 (glutaraldehyde 
crosslinking or in concentrated ammonium sulfate solution), and reduced flexibility led 
to a decrease in activity.  
Table 4.3 Relative activity of subtilisin E variants in GdmCl or SDS on different concentrations 
of substrate Suc-AAPF-pNA  
Substrate 
concentration 
(mM) 
Relative activity of WT (%) Relative activity of M4 (%) 
1 M 
GdmCl 
2 M 
GdmCl 
0.5 % 
SDS 
1 M 
GdmCl 
2 M 
GdmCl 
0.5 % 
SDS 
0.10 18 4 37 57 35 49 
0.25 17 6 34 68 46 73 
1.00 29 8 45 86 61 85 
2.00 35 12 58 82 62 85 
5.00 46 18 75 82 62 87 
 
4.4 Conclusions and outlook 
In summary, three iterative rounds of directed evolution and subsequent site 
saturation mutagenesis studies revealed that substitutions at positions 62, 97, 103, 
166, 218 and 224 improved subtilisin E resistance to GdmCl and SDS inactivation. 
 
Chapter 4 - Discussion 
119 
 
For the first time subtilisin E was engineered into a chaotolerent protease. Mutant M6 
showed highest chaotolerance towards GdmCl and SDS compared to wild type (half 
life 67.6 min in 3 M GdmCl for M6, <2 min for WT; half life 66.3 min for M6 in 2.0 % 
SDS; <2 min for WT). CD spectra results of subtilisin E in the presence of GdmCl or 
SDS indicates that inactivation precedes overall conformational changes at mild 
concentrations of these two chaotropes (1-2 M GdmCl; 0.5 -2.0 % SDS). MD 
simulations led to the hypothesis that Gdm+ ions or DS- might directly interact with 
residues at the active site or substrate binding pockets in an inhibition manner. The 
unusual finding that all substitutions surround the active site or substrate binding 
pocket residues in subtilisin E demonstrates the benefit of mutating amino acids close 
to these areas to stabilize subtilisin E against chaotropes like GdmCl or SDS. This 
approach might be of general interest for serine protease stabilization. 
    Activity of almost all GdmCl- or SDS- tolerant variants of subtilisin E (except 
SeSaM1-7) in the absence of those chaotropes was reduced towards complex protein 
substrate, like Skim-milk or Azocasein despite that their activities towards peptide 
substrate Suc-AAPF-AMC or Suc-AAPF-pNA was not reduced (see Table 3.13, 3.20, 
3.22, 3.32). Activity loss of stability improved variant could be compensated again by 
protein engineering. For instance, total activity loss of subtilisin E variant with high 
tolerance towards DMF identified by directed evolution was recovered by additional 
rounds of directed evolution [36]. Another single mutation of Ser for Ala was introduced 
into the highly conserved 83-Gly-Val-Ala-85 region of aprE (subtilisin E) which 
resulted in the generation of a subtilisin mutant with an enhanced catalytic efficiency 
due to a larger kcat. The position of the mutation was placed in the conserved 
N-terminal end of the loop that connects a β-sheet with the α-helix containing the 
catalytic residue His64 [144]. 
    It should also be noted that it is unusual in directed evolution experiments, that all 
beneficial substitutions are located around the active site or substrate binding pockets, 
especially as only a few thousand variants were sampled [29, 145]. There are some 
substitutions observed outside this region which have neutral or even adverse effects 
on chaotolerance, such as position 181, 184 (see Figure 3.16) indicated by SSM 
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studies. However, the way of construction of mutant M2, M5 and M6 by addition of 
beneficial substitutions ruled out that these substitutions might have cooperative 
effects with other substitutions. The novel method SeSaM-based shuffling was 
developed as an alternative to above recombinatorial mutagenesis to overcome this 
drawback but ended up unfortunately with complete loss of activity towards complex 
substrate (see section 3.2.2.3). Therefore, it might be alternative semi-rational 
investigation on the role of amino acid positions in close proximity to the active site 
with multi-site saturation [146] in order to further stabilize subtilisin E towards GdmCl or 
SDS.  
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Appendix I: Sequence of subtilisin E synthetic 
gene aprE (M14) 
CATATGTGGA AGAAGATCAT ATTGCACATG AATATGAGCA ATCTGTTCCT TATGGCATTT 
CTCAAATTAA AGCGCCGGCT CTTCACTCTC AAGGCTACAC AGGCTCTAAC GTAAAAGTAG 
CTGTTATCGA CAGCGGAATT GACTCTTCTC ATCCTGACTT AAACGTCAGA GGCGGAGCAA 
GCTTCGTACC TTCTGAAACA AACCCATACC AGGACGGCAT CTCTCACGGT ACGCATGTAG 
CCGGTACGAT TGCCGCTCTT AATAACTCAA TCGGTGTTCT GGGCGTTAGC CCAAGCGCAT 
CATTATATGC AGTAAAAGTG CTTGCCTCAA CAGGAAGCGG CCCATATAGC TGGATTATTA 
ACGGCATTGA GTGGGCCATT TCCAACAATA TGGATGTTAT CAACATGAGC CTTGGCGGAC 
CTACTGGTTC TACAGCGCTG AAAACAGTCG TTGACAAAGC CGTTTCCAGC GGTATCGTCG 
CTGCTGCCGC AGTCGGAAAC GAAGGTTCAT CCGGAAGCAC AAGCACAGTC AGCTACCCTG 
CAAAATATCC TTCTACTATT GCAGTAGGTG CGGTAGACAG CAGCCACCAA AGAGCTTCAT 
TCTCCAGCGC AGGTTCTGAG CTTGATGTGA TGGCTCCTGG CGTGTCCGTC CAAAGCACAC 
TTCCTGGAGG CACTTACGGC GCTTATAGCG GAACGTCCAT GGCGGCTCCT CACGTTGCCG 
GAGCAGCAGT GTTAATTCTT TCTAAGCACC CGAGTTGGAC AAACGCGCAA GTCCGTGATC 
GTTTAGAAAG CACTGCAACA TATCTTGGAA ACTCTTTCTA CTATGGAAAA GGGTTAATCA 
  ACGTACAAGC AGCTGCACAA TAA 
 
Overview of 14 amino acid substitutions 
Mutation Nucleotide  Amino acid  
1 GCG 320 GAG A1E 
2 AGT 503/504 ATC S62I 
3 GAT 608/609 GCC D97A 
4 CAA 626 CCA Q103P 
5 GTT 764 GCT V149A 
6 GCC 776 GTC A153V 
7 GGC 814 AGC G166S 
8 AAC 859 GAC N181D 
9 AAC 868 CAC N184H 
10 ATC 931 GTC I205V 
11 AAC 971 AGC N218S 
12 ACT 988 GCT T224A 
13 GCG 1013 GTG A232V 
14 ACT 1037 AGT T240S 
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